<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://www.damienbove.com/wordpress/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.3.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.6" -->
<!-- generated-on="February 20, 2012 4:46 pm" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://www.damienbove.com/</loc>
		<lastmod>2012-02-20T16:42:09+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/19/twitter-weekly-updates-for-2012-02-19/</loc>
		<lastmod>2012-02-19T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/members-area/</loc>
		<lastmod>2012-02-17T11:39:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/17/atmp-regulations-in-europe/</loc>
		<lastmod>2012-02-17T10:43:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/20/ema-published-a-draft-update-appendix-1-on-the-guidelines-on-the-evaluation-anticancer-medicinal-products-in-man/</loc>
		<lastmod>2012-02-16T16:46:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/19/ema-publishes-community-herbal-monograph-on-urtica-dioica-l-urtica-urens-l-their-hybrids-or-their-mixtures-radix/</loc>
		<lastmod>2012-02-16T16:41:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/18/ema-calls-for-scientific-data-for-use-in-hmpc-assessment-work-on-crataegus-monogyna-jacq-lindm-or-crataegus-laevigata-poir-d-c-fructus/</loc>
		<lastmod>2012-02-16T16:37:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/17/ema-call-for-scientific-data-for-use-in-hmpc-assessment-work-on-ginkgo-biloba-l-folium/</loc>
		<lastmod>2012-02-16T16:32:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/16/ema-publish-opinion-on-hmpc-herbal-mongraph-for-capsella-bursa-pastoris-l-medikus-herba/</loc>
		<lastmod>2012-02-16T16:28:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/12/twitter-weekly-updates-for-2012-02-12/</loc>
		<lastmod>2012-02-12T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/biopharma-tv/</loc>
		<lastmod>2012-02-09T16:32:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/video-training/</loc>
		<lastmod>2012-02-03T17:48:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/09/ema-make-a-call-for-scientific-data-for-use-in-assessment-of-ginko-biloba-l-folium/</loc>
		<lastmod>2012-02-02T13:46:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/08/health-canada-releases-draft-guidance-on-classification-of-observations-for-inspection-of-cells-tissues-and-organs-establishments/</loc>
		<lastmod>2012-02-02T13:38:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/07/health-canada-opens-consultation-on-cleaning-validation-guidance/</loc>
		<lastmod>2012-02-02T13:36:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/06/health-canada-publish-new-regulations-on-process-validation-for-terminal-sterilisation-of-pharmaceutical-products/</loc>
		<lastmod>2012-02-02T13:33:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/05/fda-publish-updated-guidance-on-current-good-tissue-practice-cgtp/</loc>
		<lastmod>2012-02-02T13:30:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/04/fda-publish-guidance-on-the-use-of-histology-in-biomarker-qualification-studies/</loc>
		<lastmod>2012-02-02T13:26:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/03/fda-publish-guidance-on-responding-to-unsolicited-requests-for-off-label-information-about-prescription-drugs-and-medical-devices/</loc>
		<lastmod>2012-02-02T13:21:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/02/fda-publish-guidance-on-ides-and-inds-for-repair-or-replace-knee-cartilage/</loc>
		<lastmod>2012-02-02T13:17:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/31/normal-service-to-resume-soon/</loc>
		<lastmod>2012-01-31T10:57:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/herbal-medicines-services-associate-consultant/</loc>
		<lastmod>2012-01-18T12:34:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/forum/</loc>
		<lastmod>2012-01-13T15:40:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/09/fda-publishes-guidance-on-responding-to-unsolicited-requests-for-off-label-information/</loc>
		<lastmod>2012-01-03T09:02:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/08/nice-published-detailed-review-of-service-user-experience-in-adult-mental-health/</loc>
		<lastmod>2012-01-03T08:58:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/07/nice-published-guidance-on-elucigene-fh20-and-lipochip-for-the-diagnosis-of-familial-hypercholesterolaemia/</loc>
		<lastmod>2012-01-03T08:54:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/06/nice-published-guidance-on-panitumumab-in-combination-with-chemotherapy-for-metastatic-colorectal-cancer/</loc>
		<lastmod>2012-01-03T08:51:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/05/nice-publish-guidance-on-the-use-of-fulvestrant-for-the-treatment-of-locally-advanced-or-metastatic-breast-cancer/</loc>
		<lastmod>2012-01-03T08:47:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/04/nice-publish-guidnace-on-tocilizumab-for-the-treatment-of-systemic-juvenile-idiopathic-arthirits/</loc>
		<lastmod>2012-01-03T08:42:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/03/nice-publish-guidnce-on-anaphlyaxis-assessment-confirmation-and-treatment/</loc>
		<lastmod>2012-01-03T08:37:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/31/fda-published-updated-draft-guidance-on-humanitarian-use-device-designations-hud/</loc>
		<lastmod>2011-12-19T09:57:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/30/fda-publishes-guidance-on-the-general-principles-for-the-development-of-vaccines-for-global-infectious-diseases/</loc>
		<lastmod>2011-12-19T09:52:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/29/fda-publishes-questions-and-answers-and-change-requestson-m2-ectd-specifications/</loc>
		<lastmod>2011-12-19T09:49:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/28/fda-published-guidance-on-the-regulatory-classification-of-pharmaceutical-co-crystals/</loc>
		<lastmod>2011-12-19T09:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/19/nice-published-guidance-on-ranibizumab-for-the-treatment-of-diabetic-macular-oedema/</loc>
		<lastmod>2011-12-19T09:42:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/27/fda-produces-guidelines-on-the-use-of-nucleic-acid-test-on-pooled-and-individual-donor-samples-to-reduce-risk-of-hep-b-transmission/</loc>
		<lastmod>2011-12-16T15:58:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/26/fda-releases-guidance-on-the-re-qualification-method-for-re-entry-of-donors-who-test-positive-for-hepatitis-b-following-vaccination/</loc>
		<lastmod>2011-12-16T15:54:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/25/fda-published-guidance-on-the-nonclinical-evaluation-of-therapeutic-radiopharmaceuticals/</loc>
		<lastmod>2011-12-16T15:50:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/24/nice-publishes-guidance-on-balloon-dilation-of-the-eustachian-tube/</loc>
		<lastmod>2011-12-16T15:45:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/23/nice-publishes-guidance-on-closure-of-anal-fistula-using-a-suturable-boiprosthetic-plug/</loc>
		<lastmod>2011-12-16T15:39:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/22/nice-published-guidelines-on-endoscopic-transluminal-pancreatic-necrosectomy/</loc>
		<lastmod>2011-12-13T16:07:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/21/nice-publish-guidelines-on-magnetic-resonance-imaging-guided-transcutaneous-focused-ultrasound-for-uterine-fibroids/</loc>
		<lastmod>2011-12-13T16:01:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/21/nice-publishes-guidance-on-self-harm-long-term-management/</loc>
		<lastmod>2011-12-13T10:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/20/nice-publishes-guidance-on-single-port-laparoscopic-nephrectomy/</loc>
		<lastmod>2011-12-13T10:04:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/19/ema-publish-concept-paper-on-updates-to-guidance-on-clinical-development-in-hiv/</loc>
		<lastmod>2011-12-13T10:01:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/18/fda-published-guidance-for-industry-and-staff-on-510k-device-modifications/</loc>
		<lastmod>2011-12-13T09:55:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/18/new-fda-resource-bioequivalence-recommendations-for-specific-products/</loc>
		<lastmod>2011-12-12T09:04:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/17/nice-publishes-guidance-on-colorectal-cancer-diagnosis-and-management/</loc>
		<lastmod>2011-12-12T08:58:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/16/fda-published-guidance-on-clinical-considerations-for-therapeutic-cancer-vaccines/</loc>
		<lastmod>2011-12-12T08:54:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/15/nice-publishes-guidelines-for-the-use-of-ticagrelor-in-acute-coronary-syndrome/</loc>
		<lastmod>2011-12-12T08:41:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/14/fda-publishes-guidance-for-industry-on-q8-q9-and-q10-r4-questions-and-answers/</loc>
		<lastmod>2011-12-12T08:36:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/13/mhra-publishes-a-public-consultation-on-a-consolidation-and-review-of-uk-medicines-legislation/</loc>
		<lastmod>2011-12-12T08:31:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/12/fda-publish-e2c-clinical-safety-data-management-guidance/</loc>
		<lastmod>2011-12-12T08:26:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/desk-research-services/</loc>
		<lastmod>2011-12-08T11:52:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/08/fda-publishes-draft-guidance-on-ich-e2br3-electronic-transmission-of-individual-case-safety-reports-implementation-guide/</loc>
		<lastmod>2011-12-07T16:31:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/07/ema-published-a-concept-paper-on-updating-guidance-for-medical-products-to-treat-bacterial-infections/</loc>
		<lastmod>2011-12-07T16:23:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/02/nice-publish-guidance-on-ticagrelor-in-acute-coronary-syndromes/</loc>
		<lastmod>2011-12-02T14:11:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/05/nice-publish-guidance-on-mifamurtide-for-the-treatment-of-osteosarcoma/</loc>
		<lastmod>2011-12-02T10:44:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/04/nice-publish-guidance-on-hyperglycaemia-in-acute-coronary-syndromes/</loc>
		<lastmod>2011-12-02T10:42:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/03/nice-publish-guidance-on-eos-2d3d-imaging-systems/</loc>
		<lastmod>2011-12-02T10:39:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/27/twitter-weekly-updates-for-2011-11-27/</loc>
		<lastmod>2011-11-27T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/login-2/</loc>
		<lastmod>2011-11-25T10:15:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/register/</loc>
		<lastmod>2011-11-24T15:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/profile/</loc>
		<lastmod>2011-11-24T15:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/login/</loc>
		<lastmod>2011-11-24T15:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/lostpassword/</loc>
		<lastmod>2011-11-24T15:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/transactions/</loc>
		<lastmod>2011-11-24T15:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/membership-details/</loc>
		<lastmod>2011-11-24T15:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/membership-contents/</loc>
		<lastmod>2011-11-24T15:09:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/23/should-an-ifu-for-a-medical-device-be-user-tested-in-the-same-way-as-a-pil/</loc>
		<lastmod>2011-11-23T19:58:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/30/fda-updates-guidance-on-questionnaires-for-screening-blood-donors/</loc>
		<lastmod>2011-11-21T11:05:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/29/fda-publishes-guidance-for-industry-on-warnings-and-precautions-and-contraindications/</loc>
		<lastmod>2011-11-21T11:02:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/28/fda-published-appendix-to-electronic-transmission-of-individual-case-report-safety-implementation-guide/</loc>
		<lastmod>2011-11-21T10:58:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/27/fda-update-guidance-on-electronic-transmission-of-individual-case-safety-reports-e2br3/</loc>
		<lastmod>2011-11-21T10:55:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/26/notification-of-authenticity-of-ems-certificates/</loc>
		<lastmod>2011-11-21T10:50:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/25/ema-publishes-new-information-pack-for-certificates-of-medicinal-products/</loc>
		<lastmod>2011-11-21T10:47:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/24/ema-implements-a-new-certificate-of-medicinal-products/</loc>
		<lastmod>2011-11-21T10:44:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/23/ema-updates-website-on-certificates-of-medical-products/</loc>
		<lastmod>2011-11-21T10:41:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/22/how-readable-are-clinical-trial-consent-forms-and-information-sheets/</loc>
		<lastmod>2011-11-21T10:37:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/21/fda-announced-collaboration-to-reduce-surgical-fires/</loc>
		<lastmod>2011-11-21T10:34:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/20/twitter-weekly-updates-for-2011-11-20/</loc>
		<lastmod>2011-11-20T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/20/ema-publishes-a-reflection-paper-on-methodological-issues-associated-with-pharmacgenomic-biomarkers/</loc>
		<lastmod>2011-11-14T10:19:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/19/ema-publishes-guideline-on-bioanalytical-method-validation/</loc>
		<lastmod>2011-11-14T10:15:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/18/ema-publishes-guidelines-on-clinical-investigation-of-recumbent-humanplasma-derived-factor-ix-products/</loc>
		<lastmod>2011-11-14T10:11:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/17/ema-publush-guidance-on-the-treatment-of-premenstrual-dysphotic-disorder-pmdd/</loc>
		<lastmod>2011-11-14T10:08:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/16/ema-publishes-guidance-on-quality-aspects-on-the-isolation-of-candidate-influenza-viruses-in-cell-culture/</loc>
		<lastmod>2011-11-14T10:02:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/15/ema-publish-revision-to-guidance-on-impurities-in-veterinary-medical-products/</loc>
		<lastmod>2011-11-14T09:57:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/14/ema-published-draft-guideline-on-smpc-for-plasma-derived-fibrin-sealant/</loc>
		<lastmod>2011-11-14T09:52:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/13/twitter-weekly-updates-for-2011-11-13/</loc>
		<lastmod>2011-11-13T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/16/ema-published-guidance-on-specifications-for-herbal-products/</loc>
		<lastmod>2011-11-11T11:21:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/16/ema-published-concept-paper-on-the-clinical-evaluation-are-nocieptive-and-neuropathic-pain-therapies/</loc>
		<lastmod>2011-11-11T11:17:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/15/ema-published-guideline-on-core-smpc-and-package-leaflet-for-radiopharmaceuticals/</loc>
		<lastmod>2011-11-11T11:12:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/14/dma-publishes-concept-paper-on-bio-similars-containing-proteins/</loc>
		<lastmod>2011-11-11T11:09:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/13/ema-published-concept-paper-on-the-visions-of-guidelines-for-influenza-vaccines/</loc>
		<lastmod>2011-11-11T11:05:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/12/ema-published-questions-and-answers-on-the-procedure-of-pip-compliance-verification/</loc>
		<lastmod>2011-11-11T11:01:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/11/ema-starts-review-of-orilistat-containing-medicines/</loc>
		<lastmod>2011-11-08T15:13:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/10/ema-release-concept-paper-on-pharmacovigilance-and-implementation/</loc>
		<lastmod>2011-11-08T11:27:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/09/ema-and-fda-collaborate-on-inspections-with-australia/</loc>
		<lastmod>2011-11-08T11:23:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/pharmaceutical-labeling-services/</loc>
		<lastmod>2011-11-08T09:29:54+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/08/ema-publish-reflection-paper-on-risk-based-quality-management-in-clinical-trials/</loc>
		<lastmod>2011-11-08T08:51:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/07/ema-publish-reflection-paper-on-interactive-voice-response-technologies/</loc>
		<lastmod>2011-11-07T09:31:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/06/twitter-weekly-updates-for-2011-11-06/</loc>
		<lastmod>2011-11-06T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/30/twitter-weekly-updates-for-2011-10-30/</loc>
		<lastmod>2011-10-30T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/27/getting-the-right-balance-guest-post/</loc>
		<lastmod>2011-10-27T08:28:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/31/ema-publish-guidelines-on-interactive-response-technologies-in-clinical-trials/</loc>
		<lastmod>2011-10-24T08:54:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/30/ema-publishes-public-statement-on-allium-cepa-l-bulbus/</loc>
		<lastmod>2011-10-24T08:51:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/29/ema-publishes-herbal-monograph-for-glycyrrhiza-glabra-l/</loc>
		<lastmod>2011-10-24T08:44:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/28/ema-publishes-comments-received-on-herbal-monograph-symphytum-officinale-l-radix/</loc>
		<lastmod>2011-10-24T08:40:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/27/ema-publish-community-herbal-monograph-on-fraxinus-excelsior-l/</loc>
		<lastmod>2011-10-24T08:37:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/26/ema-publish-guidance-on-smpc-for-plasma-derived-fibrin-sealant-haemostatic-products/</loc>
		<lastmod>2011-10-24T08:32:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/25/ema-publish-concept-paper-on-need-for-new-guidance-on-nociceptive-pain/</loc>
		<lastmod>2011-10-24T08:26:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/24/ema-publish-concept-paper-on-bio-similar-products-containing-active-proteins-clinical-and-non-clinical/</loc>
		<lastmod>2011-10-24T08:16:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/23/twitter-weekly-updates-for-2011-10-23/</loc>
		<lastmod>2011-10-23T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/18/game-to-be-regulated-as-a-drug/</loc>
		<lastmod>2011-10-18T15:52:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/28/ema-publish-concept-paper-on-review-of-guidelines-on-influenza-vaccine-development/</loc>
		<lastmod>2011-10-18T10:06:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/27/ema-publish-draft-guidelines-on-clinical-investigations-for-medicinal-products-in-diabetes-mellitus/</loc>
		<lastmod>2011-10-18T10:02:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/27/ema-publish-guidance-on-the-qualification-of-low-hippocampal-volume-atrophy-by-mri/</loc>
		<lastmod>2011-10-18T09:58:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/26/ema-publish-list-of-references-used-in-assessment-of-viola-arvensis-murray-vulgaris-koch/</loc>
		<lastmod>2011-10-18T09:55:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/25/ema-publish-assessment-report-on-viola-tricolor-l/</loc>
		<lastmod>2011-10-18T09:52:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/24/ema-publish-overview-of-comments-received-on-community-herbal-monograph-for-viola-tricolor-l/</loc>
		<lastmod>2011-10-18T09:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/23/health-canada-publishes-a-document-on-reviewing-the-medical-device-inspection-cycle/</loc>
		<lastmod>2011-10-18T09:45:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/22/health-canada-publishes-guidance-on-inspection-strategy-for-medical-device-companies/</loc>
		<lastmod>2011-10-18T09:37:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/21/health-canada-publish-draft-guidnace-on-gmp-for-medical-gases/</loc>
		<lastmod>2011-10-17T09:13:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/20/fda-publish-guidance-on-the-sameness-of-monoclonal-antibody-products-under-the-orphan-drug-regulations/</loc>
		<lastmod>2011-10-17T09:10:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/20/review-and-validation-of-translations-how-far-do-you-go-2/</loc>
		<lastmod>2011-10-17T09:04:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/19/fda-publish-guidance-on-physical-chemical-identifiers-for-anti-counterfeiting/</loc>
		<lastmod>2011-10-17T09:01:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/18/ema-publish-concept-paper-on-addendum-to-guidance-on-evaluation-of-treatments-for-bacterial-infections/</loc>
		<lastmod>2011-10-17T08:57:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/17/mhra-publish-updated-guidance-on-consumer-websites/</loc>
		<lastmod>2011-10-17T08:53:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/16/twitter-weekly-updates-for-2011-10-16/</loc>
		<lastmod>2011-10-16T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/medqp/medical-translation-free-copies-of-the-book/</loc>
		<lastmod>2011-10-13T09:15:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/28/fda-publish-guidance-on-container-and-closure-systems-testing/</loc>
		<lastmod>2011-10-10T08:17:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/27/fda-awards-three-grants-to-stimulate-development-of-pediatric-medical-devices/</loc>
		<lastmod>2011-10-10T08:14:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/26/mhra-publishes-updated-advertising-of-medicines-guidance/</loc>
		<lastmod>2011-10-10T08:12:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/25/fda-publishes-staff-guidance-on-de-novo-classification-and-evaluation-class-iii-devices/</loc>
		<lastmod>2011-10-10T08:10:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/24/fda-publish-guidane-on-media-fills-for-pet-drugs/</loc>
		<lastmod>2011-10-10T08:07:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/23/fda-publish-guidance-on-time-and-extent-applications-for-nonprescription-drug-products/</loc>
		<lastmod>2011-10-10T08:04:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/22/key-references-and-local-legislation-for-pil-user-testing-europe/</loc>
		<lastmod>2011-10-10T08:01:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/21/revisiting-the-%e2%80%98summative%e2%80%99-%e2%80%98formative%e2%80%99-distinction-when-approaching-pil-user-testing/</loc>
		<lastmod>2011-10-10T07:59:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/20/an-exploration-of-spc-harmonisation/</loc>
		<lastmod>2011-10-10T07:57:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/19/the-loose-end-of-auditing-translation-workflow/</loc>
		<lastmod>2011-10-10T07:55:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/18/review-and-validation-of-translations-how-far-do-you-go/</loc>
		<lastmod>2011-10-10T07:53:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/17/a-critique-of-the-linguistic-validation-process-for-patient-reported-outcomes-and-quality-of-life-instruments/</loc>
		<lastmod>2011-10-10T07:50:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/16/advancing-the-need-for-cultural-localisation-of-medical-device-software-tools/</loc>
		<lastmod>2011-10-10T07:47:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/15/nice-publish-guidance-on-multiple-pregnancy/</loc>
		<lastmod>2011-10-10T07:44:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/14/nice-publish-guidance-on-minimally-invasive-oestophagectomy/</loc>
		<lastmod>2011-10-10T07:39:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/13/nice-publish-guidance-on-autism-recognition-referal-and-diagnosis/</loc>
		<lastmod>2011-10-10T07:36:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/12/nice-publishes-guidance-on-arthroscopic-femoro-acetabular-surgery-for-his-impingement-syndrome/</loc>
		<lastmod>2011-10-10T07:32:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/11/fda-publishes-staff-guide-on-marketed-unapproved-drugs/</loc>
		<lastmod>2011-10-10T07:30:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/10/fda-publish-guidance-on-interpreting-reproductive-and-development-toxicities-reports/</loc>
		<lastmod>2011-10-10T07:24:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/09/twitter-weekly-updates-for-2011-10-09/</loc>
		<lastmod>2011-10-09T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/medqp/117-business-planning-tips-for-medtech-entrepreneurs/</loc>
		<lastmod>2011-10-04T08:03:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/18/health-canada-publishs-guidance-on-drug-submission-application-forms/</loc>
		<lastmod>2011-10-03T09:41:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/17/fda-publish-guidance-on-self-selection-studies-for-non-prescription-drugs/</loc>
		<lastmod>2011-10-03T09:37:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/16/mhra-publish-consultation-on-grisol-1-spray-p-to-gsl/</loc>
		<lastmod>2011-10-03T09:33:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/15/nice-publish-guidance-on-golimumab/</loc>
		<lastmod>2011-10-03T09:30:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/14/nice-publish-guidance-on-hypertension/</loc>
		<lastmod>2011-10-03T09:28:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/13/nice-publish-guidance-on-inditherm-patient-warming-for-hypothermia/</loc>
		<lastmod>2011-10-03T09:25:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/12/fund-101-launched/</loc>
		<lastmod>2011-10-03T09:23:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/11/fda-guidance-on-oversight-of-clinical-investigations-risk-based-approach-to-monitoring/</loc>
		<lastmod>2011-10-03T09:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/10/fda-publish-guidance-on-pet-drug-applications-2/</loc>
		<lastmod>2011-10-03T09:16:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/09/fda-publish-guidance-on-e2f-development-safety/</loc>
		<lastmod>2011-10-03T09:10:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/08/fda-publish-guidance-on-tablet-scoring-nomenclature-labeling-and-data-evaluation/</loc>
		<lastmod>2011-10-03T09:06:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/07/fda-publish-guidance-on-clinical-trial-imaging-endpoints/</loc>
		<lastmod>2011-10-03T09:00:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/06/fda-publish-guidance-on-neglected-tropical-diseases/</loc>
		<lastmod>2011-10-03T08:56:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/05/fda-publish-guidance-on-residual-drugs-in-transdermal-delivery-systems/</loc>
		<lastmod>2011-10-03T08:49:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/04/nice-publish-tech-appraisal-abatacept-for-rheumatoid-arthritis/</loc>
		<lastmod>2011-10-03T08:44:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/03/nice-publish-guidance-on-microwave-ablation-for-the-treatment-of-liver-metastases/</loc>
		<lastmod>2011-10-03T08:40:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/02/twitter-weekly-updates-for-2011-10-02/</loc>
		<lastmod>2011-10-02T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/12/theres-a-hole-in-my-bucket-the-circularity-of-discussions-around-pictograms/</loc>
		<lastmod>2011-09-27T11:09:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/11/translating-for-health-review-and-validation-procedures/</loc>
		<lastmod>2011-09-27T11:05:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/10/translating-for-health-developing-your-own-network-of-translators/</loc>
		<lastmod>2011-09-27T11:02:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/09/translating-for-health-doing-it-in-house/</loc>
		<lastmod>2011-09-27T11:00:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/08/translating-for-health-partnering-with-agencies/</loc>
		<lastmod>2011-09-27T10:58:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/07/translating-for-health-how-far-do-we-take-faithul-translations/</loc>
		<lastmod>2011-09-27T10:55:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/07/translating-for-health-a-critique-of-faithful-translations-of-patient-information-leaflets/</loc>
		<lastmod>2011-09-27T10:52:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/06/translating-for-health-product-information/</loc>
		<lastmod>2011-09-27T10:49:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/05/translating-for-health-taboo-subjects/</loc>
		<lastmod>2011-09-27T10:47:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/04/translating-for-health-translation-and-its-international-resonance/</loc>
		<lastmod>2011-09-27T10:44:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/03/translating-for-health-there-are-no-perfect-translations/</loc>
		<lastmod>2011-09-27T10:42:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/02/translating-for-health/</loc>
		<lastmod>2011-09-27T10:40:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/01/eu-pil-testing-a-2011-commentary-possible-learnings-and-references/</loc>
		<lastmod>2011-09-27T10:37:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/30/eu-pil-testing-a-2011-commentary-better-policing-of-pil-testing/</loc>
		<lastmod>2011-09-27T10:35:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/29/eu-pil-testing-a-2011-commentary-the-profile-of-pil-testers/</loc>
		<lastmod>2011-09-27T10:32:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/28/eu-pil-testing-a-2011-commentary-a-critique-of-the-gold-standard-methodology/</loc>
		<lastmod>2011-09-27T10:30:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/27/eu-pil-testing-a-2011-commentary-why-it-was-introduced/</loc>
		<lastmod>2011-09-27T10:26:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/25/twitter-weekly-updates-for-2011-09-25/</loc>
		<lastmod>2011-09-25T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/30/nice-publish-guidance-on-laproscopic-cryotherapy-for-renal-cancer/</loc>
		<lastmod>2011-09-20T08:25:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/29/nice-publish-guidance-on-hypertension-clinical-management-in-adults/</loc>
		<lastmod>2011-09-20T08:23:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/28/nice-publish-guidance-on-golimumab-in-ankylosing-spondylitis/</loc>
		<lastmod>2011-09-20T08:14:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/27/job-oppoertunity-hands-on-main-board-commercial-director-edinburgh-based/</loc>
		<lastmod>2011-09-20T08:12:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/26/fda-publish-guidance-on-e16-biomarkers-related-of-drug-or-biotechnology-product-development-context-structure-and-format-of-qualification-submissions/</loc>
		<lastmod>2011-09-20T08:09:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/25/fda-update-website-on-combination-product-definitions/</loc>
		<lastmod>2011-09-20T08:05:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/24/fda-publish-guidance-on-esubmitter-programme-from-licensed-blood-establishments/</loc>
		<lastmod>2011-09-20T08:03:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/23/fda-publish-rules-on-pet-drugs-gmp/</loc>
		<lastmod>2011-09-20T07:58:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/22/mhra-publish-document-on-classification-rules/</loc>
		<lastmod>2011-09-20T07:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/21/fda-publish-510k-guidance-when-to-submit-a-510k-for-a-change/</loc>
		<lastmod>2011-09-20T07:51:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/20/fda-publish-execptions-and-alternative-procedures-approved-under-21-cfr-640-120/</loc>
		<lastmod>2011-09-20T07:46:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/30/ema-publish-template-of-qualified-persons-declaration-of-gmp-compliance/</loc>
		<lastmod>2011-09-19T08:42:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/29/ema-publishes-guidance-on-paediatric-development-of-medicinal-products/</loc>
		<lastmod>2011-09-19T08:39:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/28/ema-publish-concept-paper-on-clinical-investigations-of-multiple-sclerosis/</loc>
		<lastmod>2011-09-19T08:36:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/27/ema-publish-guidance-on-stability-testings-for-applications-for-variations-to-marketing-authorisations/</loc>
		<lastmod>2011-09-19T08:32:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/26/ema-publish-reflection-paper-on-iv-liposomal-products/</loc>
		<lastmod>2011-09-19T08:29:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/25/ema-publish-concept-paper-on-non-clinical-local-tolerance-testing/</loc>
		<lastmod>2011-09-19T08:25:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/25/ema-publish-paper-on-revision-of-non-clinical-and-clinical-development-of-similar-biologicals-human-insulin/</loc>
		<lastmod>2011-09-19T08:01:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/24/ema-publish-guidance-on-plasma-derived-medicinal-products/</loc>
		<lastmod>2011-09-19T07:57:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/23/ema-publish-guidance-on-certificates-of-medicinal-products-filling-in-application-forms/</loc>
		<lastmod>2011-09-19T07:54:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/22/the-european-commission-publish-guidance-on-compilation-of-community-procedures-on-inspections-and-exchange-of-information/</loc>
		<lastmod>2011-09-19T07:51:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/21/ema-lists-products-not-falling-under-scope-of-medicinal-products-for-veterinary-in-foodstuffs-of-animal-origin/</loc>
		<lastmod>2011-09-19T07:46:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/20/ema-publish-procedure-for-calls-for-scientific-data-for-use-in-hmpc-assessment-work/</loc>
		<lastmod>2011-09-19T07:43:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/19/ema-publishes-procedures-on-the-systematic-review-of-community-herbal-monographs-and-supporting-documents/</loc>
		<lastmod>2011-09-19T07:39:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/30/ema-publish-procedure-on-publication-of-hmpc-statements-with-community-herbal-monographs-are-not-established/</loc>
		<lastmod>2011-09-15T09:34:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/29/ema-publishes-implementation-plan-for-qrd-and-package-leaflets/</loc>
		<lastmod>2011-09-15T09:28:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/28/ema-and-fda-set-up-biosimilar-cluster-and-publish-report/</loc>
		<lastmod>2011-09-15T09:24:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/27/ema-give-first-positive-opinion-on-paediatric-use-marketing-authorisation/</loc>
		<lastmod>2011-09-15T09:22:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/26/ema-seeks-expressions-on-interest-in-ophthalmology-workshop/</loc>
		<lastmod>2011-09-15T09:19:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/25/ema-seeks-views-on-genomic-markers-and-use-in-development/</loc>
		<lastmod>2011-09-15T09:16:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/24/ema-announces-opening-of-public-consultation-on-good-distribution-practice/</loc>
		<lastmod>2011-09-15T09:14:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/23/ema-improves-package-leaflets/</loc>
		<lastmod>2011-09-15T09:11:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/10/ema-announce-meeting-on-paedatic-regulation-in-its-5th-year/</loc>
		<lastmod>2011-09-15T09:08:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/22/ema-publishes-new-strategy-for-combating-antimicrobial-resistance/</loc>
		<lastmod>2011-09-15T09:05:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/21/ema-seeks-expression-of-interest-in-workshop-on-ethics-of-children-in-clinical-trials/</loc>
		<lastmod>2011-09-15T09:02:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/20/ema-publish-guidance-on-ich-q11-on-development-and-manufacture-of-chemical-and-biotechnology-drug-substances/</loc>
		<lastmod>2011-09-15T08:59:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/19/ema-publish-draft-guidance-on-development-of-medicines-for-paediatric-use/</loc>
		<lastmod>2011-09-15T08:56:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/18/ema-publish-paper-on-need-for-revision-of-guidelines-on-development-of-treatments-for-multiple-sclerosis/</loc>
		<lastmod>2011-09-15T08:52:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/17/ema-publish-paper-on-need-for-guidelines-on-duchenne-and-becker-muscular-dystrophy/</loc>
		<lastmod>2011-09-15T08:48:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/16/ema-publishes-reflection-paper-on-biomarkers-in-clinical-development-and-patient-selection/</loc>
		<lastmod>2011-09-15T08:43:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/15/ema-publishes-guidance-on-companies-seeking-scientific-advice-on-traditional-herbal-medicinal-products/</loc>
		<lastmod>2011-09-15T08:32:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/14/ema-publish-guidance-on-systematic-review-of-community-herbal-monograph-supporting-documents/</loc>
		<lastmod>2011-09-07T09:17:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/13/ema-publish-guidance-on-variations-to-a-marketing-authorisation/</loc>
		<lastmod>2011-09-07T09:12:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/12/ema-publishes-guidance-on-stability-testing/</loc>
		<lastmod>2011-09-07T09:09:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/10/ema-publish-paper-on-intravenous-liposomal-product-development/</loc>
		<lastmod>2011-09-07T09:06:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/09/ema-publish-guidane-on-local-tolerance-testing/</loc>
		<lastmod>2011-09-07T09:01:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/08/ema-publish-concept-paper-on-biosimilars-for-recombinant-human-insulin/</loc>
		<lastmod>2011-09-07T08:58:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/14/ema-publishes-concept-paper-on-clinical-and-non-clinical-development-of-similar-biological-medicinal-products-containing-heparins/</loc>
		<lastmod>2011-09-07T08:45:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/13/ema-announces-joint-fda-workshop-on-orphan-designation/</loc>
		<lastmod>2011-09-07T08:34:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/12/ema-announces-pharmacoepidemiology-and-pharmacovigilance-encepp-information-day/</loc>
		<lastmod>2011-09-07T08:31:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/09/ema-announce-workshop-on-statistics-in-association-with-the-drug-information-association/</loc>
		<lastmod>2011-09-07T08:23:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/08/ema-announce-meeting-on-excellence-in-pharmacovigilance-in-clinical-trials-and-post-marketing/</loc>
		<lastmod>2011-09-07T08:20:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/14/ema-annoucen-workshop-on-orphan-drug-designation/</loc>
		<lastmod>2011-09-07T08:17:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/13/ema-announce-meeting-on-antimicrobial-resistance-in-veterinary-medicines/</loc>
		<lastmod>2011-09-07T08:15:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/12/3054/</loc>
		<lastmod>2011-09-07T08:12:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/11/ema-announce-workshop-on-clinical-development-in-ophthalmology/</loc>
		<lastmod>2011-09-07T07:37:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/10/ema-announce-workshop-on-advanced-therapy-medicinal-products/</loc>
		<lastmod>2011-09-07T07:33:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/09/ema-announces-drug-development-modeling-and-simulation-workshop/</loc>
		<lastmod>2011-09-07T07:31:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/08/ema-announces-meeting-on-systems-and-process-lifecycles-in-pharmaceutical-manufacturing/</loc>
		<lastmod>2011-09-07T07:28:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/04/twitter-weekly-updates-for-2011-09-04/</loc>
		<lastmod>2011-09-04T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/07/ema-announce-meeting-on-lifecycles-in-pharmaceutical-manufacturing/</loc>
		<lastmod>2011-09-01T12:26:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/06/ema-annouce-meeting-on-ethics-for-paediatric-tirals/</loc>
		<lastmod>2011-09-01T12:23:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/05/ema-announce-meeting-on-electronic-prescribing/</loc>
		<lastmod>2011-09-01T12:20:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/04/ema-announce-meeting-on-pharmacoepidemiology-and-pharmacovigilance/</loc>
		<lastmod>2011-09-01T12:17:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/03/ema-publish-assessment-report-on-pelargonium-sidoides-dc-andor-pelargonium-reniforme-curt-radix/</loc>
		<lastmod>2011-09-01T12:14:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/02/ema-publish-overview-of-comments-received-on-community-herbal-monograph-on-tanacetum-parthenium-l-schulz-bip-herba/</loc>
		<lastmod>2011-09-01T12:12:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/01/ema-publishes-community-herbal-monograph-on-tanacetum-parthenium-l-schulz-bip-herba/</loc>
		<lastmod>2011-09-01T12:09:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/07/ema-publish-list-of-references-supporting-the-assessment-of-pelargonium-sidoides-dc-andor-pelargonium-reniforme-curt-radix/</loc>
		<lastmod>2011-09-01T12:06:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/06/ema-publishes-assessment-report-on-tanacetum-parthenium-l-schulz-bip-herba/</loc>
		<lastmod>2011-09-01T12:03:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/05/ema-publish-list-of-references-supporting-the-assessment-of-tanacetum-parthenium-l-schulz-bip-herba/</loc>
		<lastmod>2011-09-01T12:01:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/04/ema-publishes-overview-of-comments-received-on-community-herbal-monograph-on-juniperus-communis-l-aetheroleum/</loc>
		<lastmod>2011-09-01T11:58:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/03/ema-publishes-assessment-report-on-juniperus-communis-l-aetheroleum/</loc>
		<lastmod>2011-09-01T11:56:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/02/ema-publishes-list-of-references-supporting-the-assessment-of-juniperus-communis-l-aetheroleum/</loc>
		<lastmod>2011-09-01T11:52:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/01/ema-publishes-overview-of-comments-received-on-community-herbal-monograph-on-arctostaphylos-uva-ursi-l-spreng-folium/</loc>
		<lastmod>2011-09-01T11:50:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/07/ema-publish-assessment-report-on-olea-europaea-l-folium/</loc>
		<lastmod>2011-09-01T11:47:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/06/ema-publish-list-of-references-supporting-the-assessment-of-oenothera-biennis-l-oenothera-lamarckiana-l-oleum/</loc>
		<lastmod>2011-09-01T11:44:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/05/ema-publish-assessment-report-on-arctostaphylos-uva-ursi-l-spreng-folium/</loc>
		<lastmod>2011-09-01T11:41:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/04/ema-publish-list-of-references-supporting-the-assessment-of-arctostaphylos-uva-ursi-l-spreng-folium-2/</loc>
		<lastmod>2011-09-01T11:36:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/03/fda-publishes-guidance-on-inds-for-minimally-manipulated-unrelated-allogenic-placentalumbilical-cord-blood-intended-for-hemotopoietic-reconstruction/</loc>
		<lastmod>2011-09-01T11:34:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/02/mhra-approves-thr-for-lamberts-devils-claw-tablets/</loc>
		<lastmod>2011-09-01T11:29:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/01/health-canada-makes-changes-to-establishment-licenses-renewals/</loc>
		<lastmod>2011-09-01T11:25:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/free-strategic-review/</loc>
		<lastmod>2011-08-30T15:54:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/02/fda-publishes-guidance-on-q4b-dissolution-and-test-general-chapter-annex-7r2/</loc>
		<lastmod>2011-08-02T10:45:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/03/fda-publish-guidance-on-q11-development-and-manufacturing-of-drug-substances/</loc>
		<lastmod>2011-08-02T10:39:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/31/nice-publish-guidance-on-peritoneal-dialysis-for-stage-5-chronic-kidney-disease/</loc>
		<lastmod>2011-08-02T10:21:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/30/nice-publish-guidance-on-percutaneous-cryotherapy-for-renal-cancer/</loc>
		<lastmod>2011-08-02T10:18:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/29/nice-publish-guidance-on-open-femoro-acetabular-surgery-for-hip-impingement-syndrome/</loc>
		<lastmod>2011-08-02T10:15:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/28/nice-publish-guidance-on-bivalirudin-for-st-segment-elevation-myocardial-infarction/</loc>
		<lastmod>2011-08-02T10:09:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/27/nice-publish-guidance-on-bortezomib-and-thalidomide-for-multiple-myeloma/</loc>
		<lastmod>2011-08-02T10:06:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/26/nice-publish-guidance-on-mist-therapy-system-for-wound-healing/</loc>
		<lastmod>2011-08-02T10:03:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/25/nice-publishes-guidance-on-dexamethasone-intravitreal-implant-for-macular-odema/</loc>
		<lastmod>2011-08-02T10:00:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/24/nice-publish-guidance-on-retigabine-for-partial-onset-seizures-in-epilepsy/</loc>
		<lastmod>2011-08-02T09:56:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/23/nice-publish-guidance-on-endoluminal-gastroplication-for-gastro-oesophageal-reflux-disease/</loc>
		<lastmod>2011-08-02T09:53:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/22/nice-publish-guidance-on-agomelatine-for-the-treatment-of-major-depressive-episodes/</loc>
		<lastmod>2011-08-02T09:50:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/21/nice-publish-guidance-on-ambulight-pdt-for-non-melanoma-skin-cancer/</loc>
		<lastmod>2011-08-02T09:47:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/20/mhra-publish-pom-to-p-switch-proposal-for-pariet-10mg/</loc>
		<lastmod>2011-08-02T09:45:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/19/fda-publish-guidance-on-donor-history-questionnaires-for-screening-donors-of-source-plasma/</loc>
		<lastmod>2011-08-02T09:40:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/18/fda-publish-guidance-on-on-in-vitro-companion-diagnostic-devices/</loc>
		<lastmod>2011-08-02T09:37:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/17/fda-publishes-guidance-on-donors-of-blood-and-blood-components-notification-of-donor-deferral/</loc>
		<lastmod>2011-08-02T09:33:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/16/health-canada-publishes-consultation-on-post-marketing-compliance-pmrc-inspection-program/</loc>
		<lastmod>2011-08-02T09:26:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/15/ema-welcomes-new-rules-on-falsified-medicines/</loc>
		<lastmod>2011-08-02T09:23:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/14/mhra-launch-consultation-document-on-p-to-gsl-switch-for-savlon-cold-sore-cream/</loc>
		<lastmod>2011-08-02T09:20:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/13/the-ec-publishes-draft-regulation-on-electronig-instructions-for-use-of-medical-devices/</loc>
		<lastmod>2011-08-02T09:17:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/13/nice-publish-guidance-on-thoracoscopic-exclusion-of-the-left-atrial-appendage-for-non-valvular-atrial-fibrilation-for-preventing-thromboembolism/</loc>
		<lastmod>2011-08-02T09:06:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/12/nice-publish-guidance-on-golimumab-for-methotrexate-naive-rheumatoid-arthritis/</loc>
		<lastmod>2011-08-02T09:01:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/11/nice-publish-golimumab-for-the-treatment-of-rheumatoid-arthritis/</loc>
		<lastmod>2011-08-02T08:57:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/10/nice-publish-guidance-on-percutaneous-endoscopic-catheter-laser-balloon-pulmonary-vein-isolation-for-atrial-fibrillation/</loc>
		<lastmod>2011-08-02T08:54:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/09/nice-publish-guidance-on-rituximab-for-the-first-line-maintenance-treatment-of-follicular-non-hodgkins-lymphoma/</loc>
		<lastmod>2011-08-02T08:50:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/08/nice-publish-guidance-on-erlotinib-monotherapy-for-non-small-cell-lung-cancer/</loc>
		<lastmod>2011-08-02T08:47:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/07/nice-publish-guidance-on-the-management-of-hip-fracture-in-adults/</loc>
		<lastmod>2011-08-02T08:43:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/06/nice-publish-guidance-on-endoscopic-radical-inguinal-lymphadenectomy-2/</loc>
		<lastmod>2011-08-02T08:39:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/05/nice-publish-guidance-on-brahms-copeptin-assay-for-myocardial-infarction-in-patients-with-acute-chest-pain/</loc>
		<lastmod>2011-08-02T08:36:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/04/oxygen-healthcare-o2h-to-provide-chemistry-support-to-chromocell/</loc>
		<lastmod>2011-08-02T08:33:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/31/nice-publish-guidance-on-thoracoscopic-exclusion-of-the-left-atrial-appendage-for-non-valvular-atrial-fibrilation-for-thromboemobolism/</loc>
		<lastmod>2011-07-22T11:57:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/30/nice-publish-guidance-on-golimumab-for-the-treatment-of-methotrexate-naive-rheumatoid-arthritis/</loc>
		<lastmod>2011-07-22T11:53:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/29/nice-publish-guidance-on-golimumab-for-the-treatment-of-rheumatoid-arthritis-after-the-failure-of-previous-disease-modifying-anti-rheumatic-drugs/</loc>
		<lastmod>2011-07-22T11:49:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/28/nice-publish-guidance-on-percutaneous-endoscopic-catheter-laser-balloon-pulmonary-vein-isolation-for-arterial-fibrillation/</loc>
		<lastmod>2011-07-22T11:46:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/27/nice-publish-guidance-for-use-of-rituximab-for-the-treatment-of-non-hodgkins-lymphoma/</loc>
		<lastmod>2011-07-22T11:42:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/26/nice-publish-guidance-on-the-mangement-of-hip-fractures-in-adults/</loc>
		<lastmod>2011-07-22T11:33:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/25/nice-publish-guidance-on-endoscopic-radical-inguinal-lymphadenectomy/</loc>
		<lastmod>2011-07-21T10:04:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/24/nice-publish-guidance-on-brahms-copeptin-asseay-to-diagnose-myocardial-infarction/</loc>
		<lastmod>2011-07-21T09:56:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/23/fda-publishes-guidance-on-otc-sunscreen-drug-products-marketed-without-an-approved-application/</loc>
		<lastmod>2011-07-21T09:53:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/22/fda-publishes-guidance-on-non-small-cell-lung-cancer-clinical-trail-endpoints/</loc>
		<lastmod>2011-07-21T09:50:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/21/fda-publish-guidance-on-topical-acne-drug-products-for-otc-use-and-benzoyl-peroxide/</loc>
		<lastmod>2011-07-21T09:46:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/20/fda-publishes-qa-on-otc-sunscreen-products-new-requirements/</loc>
		<lastmod>2011-07-20T11:42:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/18/ema-publish-concept-paper-on-revising-chapter-8-gmp-and-risk-based-concepts/</loc>
		<lastmod>2011-07-18T09:47:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/17/twitter-weekly-updates-for-2011-07-17/</loc>
		<lastmod>2011-07-17T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/22/ema-publishes-concept-paper-on-using-ctd-format-in-traditional-herbal-medical-products-applicaions/</loc>
		<lastmod>2011-07-14T09:50:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/21/ema-publishes-draft-guidance-on-confidential-data-within-a-marketing-authorisation-dossier/</loc>
		<lastmod>2011-07-14T09:40:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/20/ema-publishes-concept-paper-on-process-validation-in-protein-products/</loc>
		<lastmod>2011-07-14T09:31:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/19/ema-publishes-list-of-references-supporting-the-assessment-of-lavandula-angustifolia-mill-aetheroleum-and-lavandula-angustifolia-mill-flos/</loc>
		<lastmod>2011-07-14T09:27:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/18/ema-publishes-community-herbal-monograph-on-lavandula-angustifolia-p-mill-flos/</loc>
		<lastmod>2011-07-14T09:25:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/17/ema-publishes-assessment-report-on-lavandula-angustifolia-mill-aetheroleum-and-lavandula-angustifolia-mill-flos/</loc>
		<lastmod>2011-07-14T09:22:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/16/ema-publishes-community-herbal-monograph-for-hamamelis-virginiana-l-cortex/</loc>
		<lastmod>2011-07-14T09:20:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/15/ema-call-for-scientific-data-for-use-in-hmpc-assessment-work-on-allium-sativum-l-bulbus/</loc>
		<lastmod>2011-07-14T09:17:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/14/ema-call-for-scientific-data-for-use-in-hmpc-assessment-work-on-eucalyptus-globulus-labill-e-polybractea-r-t-baker-and-e-smithii-r-t-baker-aetheroleum/</loc>
		<lastmod>2011-07-14T09:15:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/13/job-opportunity-senior-market-research-consultant-%e2%80%93-pharmaceutical/</loc>
		<lastmod>2011-07-13T06:44:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/13/job-opportunity-senior-eu-business-development-opportunity-%e2%80%93-pharma/</loc>
		<lastmod>2011-07-13T06:42:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/13/job-opportunity-broad-senior-marketing-manager-opportunity-pharma/</loc>
		<lastmod>2011-07-13T06:39:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/10/twitter-weekly-updates-for-2011-07-10/</loc>
		<lastmod>2011-07-10T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/05/fda-wants-to-transform-into-a-global-agency/</loc>
		<lastmod>2011-07-05T09:11:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/20/ema-call-for-scientific-data-for-use-in-hmpc-assessment-work-on-eucalyptus-globulus-labill-follium/</loc>
		<lastmod>2011-07-05T09:00:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/19/ema-publishes-community-herbal-monograph-on-valeriana-officinalis-l-radix-and-humulus-lupulus-l-flos/</loc>
		<lastmod>2011-07-05T08:57:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/18/ema-publishes-assessment-report-on-orthosiphon-stamineus-benth-folium/</loc>
		<lastmod>2011-07-05T08:54:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/17/ema-publishes-a-list-of-references-supporting-the-assessment-of-orthosiphon-stamineus-benth-folium/</loc>
		<lastmod>2011-07-05T08:51:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/16/ema-publish-overview-of-comments-received-on-community-herbal-monograph-on-orthosiphon-stamineus-benth-folium/</loc>
		<lastmod>2011-07-05T08:48:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/15/ema-publishes-list-of-references-supporting-the-assessment-of-thymus-vulgaris-l-and-thymus-zygis-l-herba-and-primula-veris-l-and-primula-elatior-l-hill-radix/</loc>
		<lastmod>2011-07-05T08:45:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/14/ema-publishes-assessment-report-on-thymus-vulgaris-l-and-thymus-zygis-l-herba-and-primula-veris-l-and-primula-elatior-l-hill-radix/</loc>
		<lastmod>2011-07-05T08:42:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/13/ema-publish-assessment-report-on-quercus-robur-l-quercus-petraea-matt-liebl-quercus-pubescens-willd-cortex/</loc>
		<lastmod>2011-07-05T08:38:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/12/ema-publish-overview-of-comments-received-on-community-herbal-monograph-on-quercus-robur-l-quercus-petraea-matt-liebl-quercus-pubescens-willd-cortex/</loc>
		<lastmod>2011-07-05T08:33:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/11/ema-publishes-list-of-references-supporting-the-assessment-of-quercus-robur-l-quercus-petraea-matt-liebl-quercus-pubescens-wild-cortex/</loc>
		<lastmod>2011-07-05T08:30:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/10/ema-publishes-overview-of-comments-received-on-community-herbal-monograph-on-cimicifuga-racemosa-l-nutt-rhizoma/</loc>
		<lastmod>2011-07-05T08:09:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/05/fda-publish-post-marketing-adverse-event-reporting-during-an-influenza-pandemic-guidance/</loc>
		<lastmod>2011-07-05T08:05:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/09/ema-publishes-list-of-references-supporting-the-assessment-of-cimicifuga-racemosa-l-nutt-rhizoma/</loc>
		<lastmod>2011-07-05T08:04:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/08/ema-publishes-assessment-report-on-cimicifuga-racemosa-l-nutt-rhizoma/</loc>
		<lastmod>2011-07-05T08:01:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/07/ema-publish-community-herbal-monograph-on-comicifuga-racemosa-l-nutt-rhizoma/</loc>
		<lastmod>2011-07-05T07:58:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/06/ema-publish-community-herbal-monograph-on-pelargonim-sidoides-dc-andor-pelargonium-reniforme-curt-radix/</loc>
		<lastmod>2011-07-05T07:37:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/05/fda-issues-guidance-on-classification-of-products-as-drugs-and-devices-additional-product-classification-issues/</loc>
		<lastmod>2011-07-05T07:33:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/03/twitter-weekly-updates-for-2011-07-03/</loc>
		<lastmod>2011-07-03T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/10/fda-publishes-guidance-on-interpretation-of-chemical-action-under-definition-of-device/</loc>
		<lastmod>2011-06-28T08:50:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/09/fda-publish-guidance-on-petitions-and-petitions-for-stay-of-action/</loc>
		<lastmod>2011-06-28T08:47:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/08/nice-publish-guidance-on-endoscopic-radiofrequency-therapy-of-the-anal-sphincter-for-faecal-incontinence/</loc>
		<lastmod>2011-06-28T08:44:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/07/nice-publish-guidance-on-identification-of-care-pathways-for-common-mental-health-disorders/</loc>
		<lastmod>2011-06-28T08:40:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/06/fda-publish-guidance-on-safety-reporting-requirements-for-inds-and-babe-studies/</loc>
		<lastmod>2011-06-28T08:37:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/05/fda-publish-guidance-on-notification-of-donor-deferral-small-entity-compliance/</loc>
		<lastmod>2011-06-28T08:34:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/04/fda-publish-guidance-on-financial-disclosure-by-clinical-investigators/</loc>
		<lastmod>2011-06-28T08:31:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/03/nice-publish-guidance-on-trabeculotomy-ab-interno-for-open-angle-glaucoma/</loc>
		<lastmod>2011-06-28T08:28:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/02/nice-publish-guidance-on-trabecular-stent-bypass-microsurgery-for-open-angle-glaucoma/</loc>
		<lastmod>2011-06-28T08:20:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/01/nice-publish-guidance-on-preventing-type-2-diabetes-in-high-risk-groups/</loc>
		<lastmod>2011-06-28T08:04:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/30/nice-publish-guidance-on-cliostazol-naftidrofuryl-oxalate-pentoxifylline-and-inositol-nicotinate-for-claudication-in-people-with-peripheral-arterial-disease/</loc>
		<lastmod>2011-06-28T07:59:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/29/nice-publish-guidance-on-tibial-nerve-stimulation-for-faecal-incontinence/</loc>
		<lastmod>2011-06-28T07:55:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/28/nice-publish-guidance-in-external-aortic-root-support-in-marfan-syndrome/</loc>
		<lastmod>2011-06-28T07:51:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/01/nice-publish-guidance-on-endoscopic-radiofrequency-therpay-of-the-anal-sphincter-for-faecal-incontinence/</loc>
		<lastmod>2011-06-20T09:50:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/30/nice-publish-guidance-on-common-mental-health-disorders/</loc>
		<lastmod>2011-06-20T09:46:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/29/ema-holds-steakholder-forum-on-pharmacovigilance/</loc>
		<lastmod>2011-06-20T09:42:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/28/ema-addresses-development-of-new-antibacterials/</loc>
		<lastmod>2011-06-20T09:39:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/27/ema-are-monitoring-products-from-japan-for-radioactivity/</loc>
		<lastmod>2011-06-20T09:37:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/26/ema-publish-reports-on-workshop-on-ethics-and-gcp-in-clinical-trials-outside-the-eu/</loc>
		<lastmod>2011-06-20T09:35:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/25/ema-publishes-agency-discussions-on-pharmacovigilance-with-french-general-inspectorate-of-social-affairs/</loc>
		<lastmod>2011-06-20T09:32:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/24/ema-publishes-guidance-on-novel-methodologies-in-the-predemntial-stage-of-alzheimers-disease-csf-biomarkers/</loc>
		<lastmod>2011-06-20T09:29:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/23/ema-publish-guidance-on-pre-submission-procedure-advice-for-users-of-the-centralised-procedure/</loc>
		<lastmod>2011-06-20T09:25:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/22/eme-publish-guidance-on-clinical-investigation-for-treatment-of-schizophrenia/</loc>
		<lastmod>2011-06-20T09:19:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/21/ema-publish-guidance-on-non-clinical-and-clinical-development-for-hiv-prevention/</loc>
		<lastmod>2011-06-20T09:16:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/20/ema-publish-guideline-on-medical-products-for-the-treatment-of-insomnia/</loc>
		<lastmod>2011-06-20T09:10:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/27/ema-publish-guidance-on-the-evaluation-of-drugs-for-gastro-oesophageal-reflux-disease/</loc>
		<lastmod>2011-06-14T08:27:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/26/ema-publish-guidance-on-ich-topic-q3cr5-impurities-for-residual-solvents/</loc>
		<lastmod>2011-06-14T08:20:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/25/ema-guidance-on-the-fate-of-veterinary-medicinal-products-in-manure/</loc>
		<lastmod>2011-06-14T08:17:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/24/ema-concept-paper-on-clinical-trials-for-stroke-and-systemic-embolic-events-in-atrial-fibrilation/</loc>
		<lastmod>2011-06-14T08:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/23/ema-reflection-paper-on-non-clinical-studies-for-generic-nanoparticle-iron-medical-products/</loc>
		<lastmod>2011-06-14T08:07:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/22/ema-publish-concept-paper-on-cvm/</loc>
		<lastmod>2011-06-14T08:05:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/21/ema-publishes-guidance-on-target-animal-safety-for-farmed-fish-veterinary-medical-products/</loc>
		<lastmod>2011-06-14T07:51:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/20/ema-publish-guidance-on-risk-mitigation-in-veterinary-medical-products/</loc>
		<lastmod>2011-06-14T07:48:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/19/fda-updated-recommendations-on-the-appropriate-use-of-long-acting-inhaled-asthma-medications-called-long-acting-beta-agonists-labas/</loc>
		<lastmod>2011-06-14T07:46:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/18/fda-requires-post-market-safety-trials-for-long-acting-beta-agonists-labas/</loc>
		<lastmod>2011-06-14T07:41:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/17/ema-publishes-concept-paper-on-efficacy-for-veterinary-antimicrobials/</loc>
		<lastmod>2011-06-14T07:39:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/16/ema-publishes-veterinary-bioequivalence-guidance/</loc>
		<lastmod>2011-06-14T07:35:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/15/ema-publishes-qrd-convention-to-be-followed-for-the-ema-qrd-templates/</loc>
		<lastmod>2011-06-14T07:32:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/14/ema-publishes-guidance-on-centrally-authorised-products-requiring-a-notification-of-a-change-2/</loc>
		<lastmod>2011-06-14T07:30:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/18/ema-concludes-class-review-of-bisphosphonates-and-atypical-fractures/</loc>
		<lastmod>2011-06-06T08:23:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/17/ema-publish-concept-paper-on-cvmp-guideline-for-efficacy-in-veterinary-antimicrobial-substances/</loc>
		<lastmod>2011-06-06T08:20:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/16/ema-publish-community-herbal-monograph-on-cola-nitida-vent-schott-et-endl-and-its-varieties-and-cola-acuminata-p-beauv-schott-et-endl-semen/</loc>
		<lastmod>2011-06-06T08:17:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/15/ema-publish-community-herbal-monograph-on-oenothera-biennis-l-oenothera-lamarckiana-l-oleum-2/</loc>
		<lastmod>2011-06-06T08:14:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/14/ema-publishes-public-statement-on-syzygium-aromaticum-l-merill-et-l-m-perry-flos/</loc>
		<lastmod>2011-06-06T08:12:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/13/ema-publish-community-herbal-monograph-on-oenothera-biennis-l-oenothera-lamarckiana-l-oleum/</loc>
		<lastmod>2011-06-06T08:08:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/12/ema-publish-community-herbal-monograph-for-cola-nitida-vent-schott-et-endl/</loc>
		<lastmod>2011-06-06T08:05:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/11/fda-publish-guidance-on-submission-of-summary-bioequivalence-data-for-andas/</loc>
		<lastmod>2011-06-06T08:01:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/10/nice-publish-report-on-preventing-type-2-diabetes/</loc>
		<lastmod>2011-06-06T07:58:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/09/fda-publish-guidance-on-dosage-delivery-devices-for-oral-otc-liquids/</loc>
		<lastmod>2011-06-06T07:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/08/fda-publish-guidance-on-computer-crossmatch-of-donor-cells/</loc>
		<lastmod>2011-06-06T07:52:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/07/nice-publish-guidance-on-romiplostim-in-thrombocytopenic-purpura/</loc>
		<lastmod>2011-06-06T07:49:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/06/fda-publish-guidance-on-processingreprocessing-medical-devices-in-health-care-settings/</loc>
		<lastmod>2011-06-06T07:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/31/nice-publish-guidance-on-stent-insertion-for-bleeding-oesophageal-varices/</loc>
		<lastmod>2011-05-26T11:20:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/30/nice-publish-guidance-on-golimumab-for-the-treatment-of-psoriatic-arthritis/</loc>
		<lastmod>2011-05-26T11:18:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/29/nice-publish-guidance-on-trabectedin-for-treatment-of-relapsed-ovarian-cancer/</loc>
		<lastmod>2011-05-26T11:16:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/28/nice-publish-clinical-guidance-on-ovarian-cancer-recognition-and-initial-management/</loc>
		<lastmod>2011-05-26T11:13:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/27/nice-publish-guidance-on-lung-cancer-diagnosis-and-treatment/</loc>
		<lastmod>2011-05-26T11:10:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/26/nice-publish-guidance-on-extracorporeal-membrane-oxygenation-for-severe-acute-respiratory-failure/</loc>
		<lastmod>2011-05-26T11:08:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/31/nice-technology-appraisal-of-everolimus-for-advanced-renal-cell-carcinoma/</loc>
		<lastmod>2011-05-25T15:53:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/30/nice-publish-guidance-on-endovascular-stent-grafting-of-popliteal-aneurysms/</loc>
		<lastmod>2011-05-25T15:51:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/29/nice-publish-guidance-on-carotid-artery-stent-placement-in-extracranial-carotid-stenosis/</loc>
		<lastmod>2011-05-25T15:47:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/28/nice-publish-guidance-on-carotid-artery-stent-placement/</loc>
		<lastmod>2011-05-25T15:44:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/27/nice-publish-guidance-on-everolimus-for-renal-cell-carcinoma/</loc>
		<lastmod>2011-05-25T15:40:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/26/tsb-annoucnes-grant-for-rd/</loc>
		<lastmod>2011-05-25T15:38:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/25/ema-and-fda-accounts-parallel-assessment-of-quality-by-design-applications/</loc>
		<lastmod>2011-05-25T15:28:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/31/ema-procedural-advice-on-combination-advanced-therapy-medicinal-products-atmps/</loc>
		<lastmod>2011-05-23T13:48:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/30/ema-publishes-post-authorisation-procedural-advice-for-human-medicinal-products/</loc>
		<lastmod>2011-05-23T13:45:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/29/ema-publishes-procedural-advice-on-fee-reductions-for-designated-orphan-medicinal-products/</loc>
		<lastmod>2011-05-23T13:42:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/28/ema-releases-qrd-templates/</loc>
		<lastmod>2011-05-23T13:39:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/27/eu-clinical-trials-register-goes-live/</loc>
		<lastmod>2011-05-23T13:36:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/26/ema-recommendation-of-labelling-and-packaging-for-non-prescription-medicines-released/</loc>
		<lastmod>2011-05-23T13:33:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/25/ema-launches-consultation-on-replacement-of-animal-studies/</loc>
		<lastmod>2011-05-23T13:30:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/25/ema-issues-reminders-on-pip-deferral-obligations/</loc>
		<lastmod>2011-05-23T12:58:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/24/ema-statement-on-herbal-products-containing-thujone/</loc>
		<lastmod>2011-05-23T12:56:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/23/ema-concept-paper-on-quality-of-biosimilar-proteins/</loc>
		<lastmod>2011-05-23T12:52:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/31/ema-publish-guideline-on-warning-on-transmissible-agents-in-smpcs-for-plansma-derived-medicinal-products/</loc>
		<lastmod>2011-05-23T09:37:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/30/ema-concept-paper-on-potency-declaration-labelling-for-modified-biologicals/</loc>
		<lastmod>2011-05-23T09:32:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/29/ema-reflection-paper-on-testing-and-risk-assessment-for-plants/</loc>
		<lastmod>2011-05-23T09:29:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/28/ema-publish-guideline-on-smpc-package-leaflet-for-radiopharamceuticals/</loc>
		<lastmod>2011-05-23T09:24:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/27/ema-publish-guidance-on-design-of-safety-and-efficacy-studies-for-fish-vaccines/</loc>
		<lastmod>2011-05-23T09:21:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/26/ema-publuish-guidance-on-production-and-control-of-immunological-veterinary-medicinal-products/</loc>
		<lastmod>2011-05-23T09:18:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/25/ema-publish-guidance-on-on-pack-design-and-labelling/</loc>
		<lastmod>2011-05-23T09:14:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/24/ema-publish-list-of-references-supporting-the-assessment-of-fumaria-officinalis-l-herba/</loc>
		<lastmod>2011-05-23T09:11:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/23/ema-publish-assessment-report-on-fumaria-officinalis-l-herba-2/</loc>
		<lastmod>2011-05-23T09:08:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/09/damien-speak-at-v-international-forum-on-advanced-parkinsons-disease/</loc>
		<lastmod>2011-05-09T10:51:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/22/ema-publish-guidance-on-residual-veterinary-drugs-in-human-food/</loc>
		<lastmod>2011-05-09T09:04:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/21/ema-publish-concept-paper-on-need-for-guidance-with-stroke-and-systemic-embolic-events-in-patients-with-atrial-fibrillation/</loc>
		<lastmod>2011-05-09T09:02:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/20/ema-publish-concept-paper-on-need-for-revision-of-the-position-on-the-replacement-of-animal-studies-by-in-vitro-models/</loc>
		<lastmod>2011-05-09T08:57:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/19/ema-publishes-concept-paper-on-revising-chapter-8-of-ec-guide-to-gmp-increased-risk-based-concepts/</loc>
		<lastmod>2011-05-09T08:54:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/18/ema-call-for-scientific-data-for-use-in-hmpc-assessment-of-camellia-sinensis-l-kuntze-non-fermentatum-folium/</loc>
		<lastmod>2011-05-09T08:50:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/17/ema-call-for-scientific-data-for-use-in-hmpc-assessment-of-capsicum-annuum-l-minimum-miller-heiser-and-capsicum-frutescens-l-fructus/</loc>
		<lastmod>2011-05-09T08:47:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/16/ema-call-for-scientific-data-for-use-in-hmpc-assessment-of-panax-ginseng-meyer-radix/</loc>
		<lastmod>2011-05-09T08:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/15/ema-nanomedicine-meeting-2011/</loc>
		<lastmod>2011-05-09T08:42:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/14/pdaema-2011-conference/</loc>
		<lastmod>2011-05-09T08:40:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/13/eudravigilance-information-day/</loc>
		<lastmod>2011-05-09T08:37:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/12/ema-sme-workshop-scientific-and-regulatory-advice/</loc>
		<lastmod>2011-05-09T08:34:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/11/ema-efpia-information-day-2011/</loc>
		<lastmod>2011-05-09T08:32:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/10/ema-announces-transatlantic-workshop-drug-related-progressive-multifocal-leukoencephalopathy/</loc>
		<lastmod>2011-05-09T08:29:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/09/ema-publish-community-herbal-monograph-on-echinacea-angustifolia-dc-radix/</loc>
		<lastmod>2011-05-09T08:26:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/contact-damien/</loc>
		<lastmod>2011-05-03T14:18:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/10/ema-publish-assessment-report-on-trigonella-foenum-graecum-l-semen/</loc>
		<lastmod>2011-05-03T08:31:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/09/ema-publishes-list-of-references-supporitng-the-assessment-of-trigonella-foenum-graecum-l-semen/</loc>
		<lastmod>2011-05-03T08:28:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/08/overview-of-comments-received-on-community-herbal-monograph-on-trigonella-foenum-gracum-l-semen/</loc>
		<lastmod>2011-05-03T08:24:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/07/ema-call-for-scientific-data-for-use-in-hmpc-assessment-work-on-camellia-sinesnsis-l-kuntze-non-fermentatum-folium/</loc>
		<lastmod>2011-05-03T08:21:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/06/ema-call-for-scientific-data-for-use-in-hmpc-assessment-work-on-capsicum-annum-lvar-minimum-miller-heiser-and-capsicum-frutescens-l-fructus/</loc>
		<lastmod>2011-05-03T08:18:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/05/ema-calls-for-scientific-data-for-use-in-hmpc-assessment-work-on-panax-ginseng-meyer-radix/</loc>
		<lastmod>2011-05-03T08:13:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/04/ema-call-for-scientific-data-for-use-in-hmpc-assessment-work-on-paullinia-cupana-junth-semen/</loc>
		<lastmod>2011-05-03T08:10:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/03/ema-publish-opinon-on-community-herbal-monograph-on-trigonella-foenum-graecum-l-semen/</loc>
		<lastmod>2011-05-03T08:06:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/19/doncaster-solicitor-service-launched/</loc>
		<lastmod>2011-04-19T21:26:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/27/fda-publish-guidance-how-to-write-a-request-for-designation/</loc>
		<lastmod>2011-04-18T09:00:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/26/fda-publish-guidance-for-industry-on-developing-treatmentsprophylaxis-for-influenza/</loc>
		<lastmod>2011-04-18T08:57:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/25/fda-publish-guidance-on-safety-labeling-changes/</loc>
		<lastmod>2011-04-18T08:54:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/24/ema-call-for-scientific-data-on-mhpc-assessment-of-erysimum-officinale-l-flos/</loc>
		<lastmod>2011-04-18T08:50:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/23/ema-calls-for-scientific-data-for-assessment-on-andrographis-paniculata-nees-folium/</loc>
		<lastmod>2011-04-18T08:47:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/22/ema-publish-list-of-supporting-references-for-assessment-of-chamaemelum-nobile-l-all-flos/</loc>
		<lastmod>2011-04-18T08:41:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/21/ema-publish-assessment-report-on-chamaemelum-nobile-l-all-flos/</loc>
		<lastmod>2011-04-18T08:39:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/20/ema-publish-assessment-report-on-agropyron-repens-l-p-beauv-rhizoma/</loc>
		<lastmod>2011-04-18T08:36:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/19/ema-publish-references-supporting-the-assessment-of-agropyron-repens-l-p-beauv-rhizoma/</loc>
		<lastmod>2011-04-18T08:30:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/18/ema-publish-list-of-references-supporting-the-assessment-of-potentilla-erecta-l-raeusch-rhizoma/</loc>
		<lastmod>2011-04-18T08:27:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/oncology-pharma-fast-tracking-oncology-technologies-into-man/</loc>
		<lastmod>2011-04-12T12:29:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/18/ema-publish-comments-received-on-herbal-mongraph-potentilla-erecta-l-raeusch-rhizoma/</loc>
		<lastmod>2011-04-11T09:08:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/17/ema-publish-references-for-syzygium-aromaticum-l-merill-et-l-m-perry-flos-and-floris-aetheroleum/</loc>
		<lastmod>2011-04-11T09:05:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/17/ema-publish-list-of-reference-to-support-fumaria-officinalis-l-herba/</loc>
		<lastmod>2011-04-11T09:02:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/16/mhra-publish-guidance-on-organic-herbal-ingredients-and-labelling-under-thr/</loc>
		<lastmod>2011-04-11T08:59:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/15/fda-publish-guidance-on-postmarketing-studies-and-clinical-trials/</loc>
		<lastmod>2011-04-11T08:56:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/14/fda-publish-guidance-on-exception-from-informed-consent-requirements-in-emergenicy-research/</loc>
		<lastmod>2011-04-11T08:53:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/13/mhra-launches-for-notification-scheme-for-clinical-trials/</loc>
		<lastmod>2011-04-11T08:49:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/12/100m-new-money-announced-for-sciecne/</loc>
		<lastmod>2011-04-11T08:46:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/11/ema-publish-assessment-report-on-fumaria-officinalis-l-herba/</loc>
		<lastmod>2011-04-11T08:41:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/15/nice-publish-cardioq-odm-oesophageal-doppler-monitor-guidance/</loc>
		<lastmod>2011-04-04T08:49:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/14/fda-publish-guidance-on-cord-blood-processing-system-and-storage/</loc>
		<lastmod>2011-04-04T08:46:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/13/nice-publish-guidance-on-donepezil-galantamine-rivastigmine-and-memantine-for-alzheimers/</loc>
		<lastmod>2011-04-04T08:43:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/12/nice-publish-guidance-on-colonoscopic-surveillance-for-colorectal-cancer/</loc>
		<lastmod>2011-04-04T08:38:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/11/nice-publish-guide-on-deep-brain-stimulation-for-intractable-trigeminal-autonomic-cephalalgias/</loc>
		<lastmod>2011-04-04T08:35:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/10/nice-publish-guidance-on-deep-brain-stimultion-for-refractory-chronic-pain-syndromes/</loc>
		<lastmod>2011-04-04T08:31:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/09/nice-publish-guidance-on-diabetic-foot-problems/</loc>
		<lastmod>2011-04-04T08:29:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/08/nice-publish-guidance-on-hand-allotransplantation/</loc>
		<lastmod>2011-04-04T08:26:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/07/nice-publish-guidance-on-increasing-update-of-hiv-testing/</loc>
		<lastmod>2011-04-04T08:22:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/06/nice-publish-guidance-for-laser-correction-of-refractive-error/</loc>
		<lastmod>2011-04-04T08:20:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/05/nice-publish-guidance-on-moorld12-bi-a-laser-doppler-blood-flow-imager-for-burn-assessment/</loc>
		<lastmod>2011-04-04T08:17:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/04/nice-publish-guide-on-azacitidine-for-myelodysplastic-syndromes-myelomonocytic-leukaemia-and-acute-myeloid-leukaemia/</loc>
		<lastmod>2011-04-04T08:13:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/03/twitter-weekly-updates-for-2011-04-03/</loc>
		<lastmod>2011-04-03T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/23/budget-news-goverment-to-reduce-the-approval-time-for-clinical-trials/</loc>
		<lastmod>2011-04-01T13:59:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/31/job-opportunity-senior-regulatory-affairs-manager-scotland/</loc>
		<lastmod>2011-03-31T15:04:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/medqp/course/</loc>
		<lastmod>2011-03-31T08:11:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/31/nice-publish-guidance-on-percutaneous-retroperitoneal-endoscopic-necrosectomy/</loc>
		<lastmod>2011-03-29T08:44:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/30/nice-publish-guidance-on-psychosis-with-coexisting-substance-misuse/</loc>
		<lastmod>2011-03-29T08:41:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/29/nice-publish-guidance-on-therapeutic-hypothermia-following-cardiac-arrest/</loc>
		<lastmod>2011-03-29T08:39:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/31/nice-publish-guidance-on-transaxial-interbody-lumbosacral-fusion/</loc>
		<lastmod>2011-03-29T08:36:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/30/nice-publish-guidance-on-tuberculosis/</loc>
		<lastmod>2011-03-29T08:33:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/29/free-pitching-events-managed-by-angel-news/</loc>
		<lastmod>2011-03-29T08:32:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/31/biocity-boot-camp-for-bioentrepreneurs-6th-8th-april-notingham/</loc>
		<lastmod>2011-03-29T08:30:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/30/bupa-foundation-strategy-fund/</loc>
		<lastmod>2011-03-29T08:27:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/29/fda-publish-guidance-on-user-fee-waivers-reductions-and-refunds/</loc>
		<lastmod>2011-03-29T08:23:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/29/fda-publish-guidance-on-hypertension-indication-drug-labeling-claims/</loc>
		<lastmod>2011-03-28T13:46:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/28/fda-publish-guidance-on-non-penicillin-beta-lactam-risk-assessment/</loc>
		<lastmod>2011-03-21T10:11:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/27/fda-publish-guidance-on-the-effects-of-high-absenteeism-on-availability-of-drugs/</loc>
		<lastmod>2011-03-21T10:06:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/26/nice-publish-guidance-on-alcohol-use-disorders-3/</loc>
		<lastmod>2011-03-21T10:04:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/25/deputy-pm-announces-new-round-of-the-regional-growth-fund/</loc>
		<lastmod>2011-03-21T10:01:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/24/mhra-publish-guidance-on-homeopathic-medicines-advertising/</loc>
		<lastmod>2011-03-21T09:59:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/22/fda-publish-guidance-on-process-validation-general-principles-and-practices/</loc>
		<lastmod>2011-03-21T09:53:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/21/fda-publish-sample-formats-for-cmc-sections/</loc>
		<lastmod>2011-03-21T09:48:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/23/fda-publish-guidance-on-pet-drug-applications/</loc>
		<lastmod>2011-03-17T14:12:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/22/nice-publish-guidance-on-alcohol-use-disorders-2/</loc>
		<lastmod>2011-03-17T14:09:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/21/mhra-publish-guidance-on-clinical-trials-for-devices/</loc>
		<lastmod>2011-03-17T14:06:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/20/mhra-publish-best-practice-in-reporting-individual-case-safety-reports-icsrs/</loc>
		<lastmod>2011-03-17T14:02:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/19/mhra-publish-homeopathic-medicines-advertising-guide/</loc>
		<lastmod>2011-03-17T13:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/18/fda-publish-guidance-on-risk-evaluation-mitigation-strategies-rems/</loc>
		<lastmod>2011-03-17T13:55:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/17/nice-publish-guidance-on-pazopanib-for-renal-cell-carcinoma-2/</loc>
		<lastmod>2011-03-17T13:51:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/13/nice-publish-guidance-on-bendamustine-for-leukaemia/</loc>
		<lastmod>2011-03-08T14:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/12/nice-publish-guidance-on-food-allergy-in-children/</loc>
		<lastmod>2011-03-08T14:40:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/11/nice-publish-guidance-on-bevacizumab-in-breast-cancer/</loc>
		<lastmod>2011-03-08T14:38:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/10/nice-publish-guidance-on-anaemia-in-chronic-kidney-disease/</loc>
		<lastmod>2011-03-08T14:36:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/09/nice-publish-guidance-on-alcohol-use-disorders/</loc>
		<lastmod>2011-03-08T14:33:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/08/ema-publish-guideline-on-hep-c-therapies/</loc>
		<lastmod>2011-03-08T14:30:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/10/ema-publish-concept-paper-on-hiv-prevention-medical-products/</loc>
		<lastmod>2011-03-03T10:27:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/09/six-month-suspended-sentence-for-selling-and-supplying-herbal-medicines-without-a-marketing-authorisation/</loc>
		<lastmod>2011-03-03T10:24:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/08/mhra-publish-annual-report-on-medicines-advertising/</loc>
		<lastmod>2011-03-03T10:20:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/07/nice-publish-guidance-on-pazopanib-for-renal-cell-carcinoma/</loc>
		<lastmod>2011-03-03T10:18:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/06/nice-publish-guidance-on-percutaneous-atherectomy-of-femoropopliteal-arterial-lesions/</loc>
		<lastmod>2011-03-03T10:14:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/05/nice-publish-guidance-on-bedamustine-in-leukaemia/</loc>
		<lastmod>2011-03-03T10:06:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/04/nice-publish-reference-guide-on-food-allergy-in-children/</loc>
		<lastmod>2011-03-03T10:03:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/03/nice-publish-guidance-on-bevacizumab-and-taxane-in-breast-cancer/</loc>
		<lastmod>2011-03-03T10:00:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/01/ema-publish-guideline-on-clinical-evaluation-of-treatments-for-hepatitis-c/</loc>
		<lastmod>2011-02-24T10:29:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/28/mhra-publish-guidance-on-best-practice-in-reporting-individual-case-safety-reports-icsrs/</loc>
		<lastmod>2011-02-24T10:25:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/27/fda-publish-guidance-on-clinical-pharmacogenomics-premarketing-evaluation/</loc>
		<lastmod>2011-02-24T10:22:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/26/fda-publish-best-practice-for-pharmacoepidemiologic-safety-studies-with-electronic-data-sets/</loc>
		<lastmod>2011-02-24T10:18:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/25/fda-publish-guidance-on-potency-tests-for-cellular-and-gene-therapy-products/</loc>
		<lastmod>2011-02-24T10:14:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/24/ema-publishes-guideline-on-clinical-evaluation-of-medicinal-products-for-the-treatment-of-chronic-hepatitis-c/</loc>
		<lastmod>2011-02-24T10:10:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/20/twitter-weekly-updates-for-2011-02-20/</loc>
		<lastmod>2011-02-20T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/21/doh-publishes-draft-acute-oncology-measures/</loc>
		<lastmod>2011-02-15T14:06:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/20/mhra-publish-guidance-on-endometrial-ablation/</loc>
		<lastmod>2011-02-15T14:03:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/19/nice-publish-rapid-update-on-anaemia-managment-in-chronic-kidney-disease/</loc>
		<lastmod>2011-02-15T14:01:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/18/mhra-publish-guidance-on-best-practice-for-ensuring-efficicent-supply-and-distribution-of-medicines/</loc>
		<lastmod>2011-02-15T13:58:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/17/fda-publish-guidance-on-pet-drug-ndas-and-andas/</loc>
		<lastmod>2011-02-15T13:55:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/16/fda-publish-guidance-on-pre-storage-leukocyte-reduction-for-blood-intended-for-transfusion/</loc>
		<lastmod>2011-02-15T13:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/15/mhra-launch-joint-working-group-on-endovascular-aneurysm-repair-service/</loc>
		<lastmod>2011-02-15T13:47:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/14/nice-publish-guidance-on-skin-cancer/</loc>
		<lastmod>2011-02-07T16:39:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/13/nice-publish-guidance-on-generalised-anxiety-disorder-and-panic-disorder-in-adults/</loc>
		<lastmod>2011-02-07T16:35:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/12/nice-issue-guidance-on-thoracoscopic-repair-of-congenital-diaphragmatic-hernia-in-neonates/</loc>
		<lastmod>2011-02-07T16:31:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/11/nice-publishes-guidance-on-aripiprazole-for-the-treatment-of-schizophrenia/</loc>
		<lastmod>2011-02-07T16:28:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/10/nice-issue-guidance-on-percutaneous-laser-coronary-angioplasty/</loc>
		<lastmod>2011-02-07T16:25:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/09/nice-publish-review-of-osteoportic-fragility-fracture-prevention-drugs/</loc>
		<lastmod>2011-02-07T16:20:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/08/nice-publish-guidance-on-off-pump-coronary-artery-bypass-grafting/</loc>
		<lastmod>2011-02-07T16:07:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/07/nice-publish-guidance-on-distal-iliotibial-band-lengthening-for-trochanteric-pain-syndrome/</loc>
		<lastmod>2011-02-07T16:04:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/13/nice-publish-guidance-on-generalised-anxiety-disorder-and-panic-disorder/</loc>
		<lastmod>2011-02-02T17:00:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/12/fda-publishes-guidance-on-process-validation/</loc>
		<lastmod>2011-02-02T16:56:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/11/ema-has-guide-on-certificates-of-medicinal-products-issued-by-ema/</loc>
		<lastmod>2011-02-02T16:53:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/10/doh-has-short-guide-on-certificate-of-free-sale-appliation-system-available/</loc>
		<lastmod>2011-02-02T16:47:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/09/mhra-announce-review-of-medicines-act-plr-regime-and-homeopathy/</loc>
		<lastmod>2011-02-02T16:44:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/08/fda-publish-infomration-for-consumers-on-cord-blood-banking/</loc>
		<lastmod>2011-02-02T16:40:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/07/fda-updates-inactive-ingredients-database/</loc>
		<lastmod>2011-02-01T12:17:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/06/fda-publish-report-on-pmrpmc-backlog-review/</loc>
		<lastmod>2011-02-01T12:14:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/05/ema-publish-guidance-on-minimum-quality-and-non-clinical-data-for-certification-of-atmps/</loc>
		<lastmod>2011-02-01T12:10:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/04/ema-publish-reflection-paper-on-stability-testing-for-herbal-medicinal-products/</loc>
		<lastmod>2011-02-01T12:05:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/03/ema-reflection-paper-on-the-use-of-macrolides-lincosamides-and-stretpgramins-in-food-producing-animals/</loc>
		<lastmod>2011-02-01T11:55:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/02/guideline-on-evidence-needed-to-avoid-ec-regulation-4702009/</loc>
		<lastmod>2011-02-01T11:50:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/01/ema-publish-guidance-on-veterinary-products-for-varroa-destructor-parasitosis-in-bees/</loc>
		<lastmod>2011-02-01T11:45:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/30/fda-issues-guidance-on-size-of-beads-in-drugs-labeled-for-sprinkle/</loc>
		<lastmod>2011-02-01T11:40:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/31/ema-publish-guideline-on-bio-similar-monoclonals/</loc>
		<lastmod>2011-02-01T11:38:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/30/ema-publish-guideline-on-immunogenicity-assessment-of-monoclonals-for-clinical-use/</loc>
		<lastmod>2011-01-28T10:26:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/29/ema-publishes-guidance-on-submission-of-variations-for-flue-vaccines/</loc>
		<lastmod>2011-01-28T10:14:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/28/ema-publish-guidance-on-core-smpc-for-human-normal-ivig/</loc>
		<lastmod>2011-01-28T09:57:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/25/ema-publish-ich-q4b-annex-7r2-gudiance-on-dissolution-tests/</loc>
		<lastmod>2011-01-24T16:08:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/24/ema-release-ich-q8q9-and-q10-qa-volume-4/</loc>
		<lastmod>2011-01-24T16:03:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/</loc>
		<lastmod>2011-01-21T15:41:50+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/29/nice-issues-guidance-on-bevacizumaboxaliplatin-combinations-in-colorectal-cancer/</loc>
		<lastmod>2011-01-21T14:16:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/28/mhra-publishes-draft-for-comment-joint-relpacement-vigilance-systems/</loc>
		<lastmod>2011-01-20T11:22:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/27/mhra-publish-guidance-for-manufactures-on-clinical-investigations-in-the-uk/</loc>
		<lastmod>2011-01-20T11:18:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/26/fda-guidance-on-postmarket-adverse-event-reporting-for-medical-products-durring-influenza-pandemic/</loc>
		<lastmod>2011-01-20T11:13:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/25/fda-publish-guidance-on-electronic-source-documentation-in-clinical-investigations/</loc>
		<lastmod>2011-01-20T11:08:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/24/fda-publish-guidance-on-lookback-for-hepc-in-donor-blood/</loc>
		<lastmod>2011-01-18T14:33:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/23/nice-publish-guidance-on-bevacizumab-for-metastatic-colorectal-cancer/</loc>
		<lastmod>2011-01-18T14:29:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/22/mhra-open-consultation-on-podiatrist-prescribing/</loc>
		<lastmod>2011-01-18T14:25:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/21/mhra-publishes-draft-guidance-on-vigilance-systems-for-joint-implants/</loc>
		<lastmod>2011-01-18T14:22:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/20/nice-publish-guidance-on-low-intensity-pulsed-ultrasound-for-fracture-healing/</loc>
		<lastmod>2011-01-18T14:18:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/19/nice-publish-guidance-on-cryotherapy-for-liver-metastases/</loc>
		<lastmod>2011-01-18T14:14:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/18/nice-publish-guidance-on-prucalopride-for-chronic-constipation/</loc>
		<lastmod>2011-01-18T14:09:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/14/ema-publish-qa-on-post-approval-change-mangement-protocols/</loc>
		<lastmod>2011-01-03T11:52:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/13/ema-publish-ich-guidance-on-q8q9-and-q10/</loc>
		<lastmod>2011-01-03T11:49:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/12/ema-publish-practicle-information-for-sponsors-for-orphan-drug-applications/</loc>
		<lastmod>2011-01-03T11:46:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/11/ema-publish-procedural-advice-on-certification-of-quality-and-non-clinial-data-for-atmp/</loc>
		<lastmod>2011-01-03T11:43:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/10/ema-publishes-comments-received-on-cmc-and-non-clinical-for-advanced-therapy-products/</loc>
		<lastmod>2011-01-03T11:37:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/09/ema-publishes-guidance-on-centrally-authorised-products-requiring-a-notification-of-a-change/</loc>
		<lastmod>2011-01-03T11:34:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/08/ema-publish-concept-paper-on-gmp-quality-control/</loc>
		<lastmod>2011-01-03T11:31:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/07/ema-publish-concept-paper-on-storage-conditions-during-transport-2/</loc>
		<lastmod>2011-01-03T11:28:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/06/fda-publishes-guidance-on-open-public-advisory-committee-meetings/</loc>
		<lastmod>2011-01-03T11:25:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/05/nice-publishes-guidance-on-cryotherapy-for-liver-metastases/</loc>
		<lastmod>2011-01-03T11:21:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/04/nice-publish-guidance-on-prucalopride-for-constipation/</loc>
		<lastmod>2011-01-03T11:18:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/03/nice-publish-guidance-on-dorsal-rhizotomy-for-cerebral-palsy/</loc>
		<lastmod>2011-01-03T11:15:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/31/nice-publishes-guidance-on-sedation-in-children-and-young-people/</loc>
		<lastmod>2010-12-20T09:40:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/30/nice-publishes-guidance-on-radiotherapy-for-lung-cancer/</loc>
		<lastmod>2010-12-20T09:32:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/29/nice-publishes-guidance-on-paradoxical-embolism-in-divers/</loc>
		<lastmod>2010-12-20T09:28:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/28/nice-publish-guidance-on-migraine-surgery/</loc>
		<lastmod>2010-12-20T09:23:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/27/fda-publish-guidance-on-inds-in-combination/</loc>
		<lastmod>2010-12-20T09:18:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/26/fda-publishes-guidance-on-impurities-in-andas/</loc>
		<lastmod>2010-12-20T09:16:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/25/fda-guidance-on-hospital-acquired-bacterial-infection-drugs/</loc>
		<lastmod>2010-12-20T09:12:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/24/fda-publish-guidance-on-noninferiority-trials-for-antibacterial-drugs/</loc>
		<lastmod>2010-12-20T09:05:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/23/ema-publish-guidance-on-novel-renal-biomarkers-for-toxicity/</loc>
		<lastmod>2010-12-20T08:58:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/22/ema-publish-output-of-policy-on-access-to-documents/</loc>
		<lastmod>2010-12-20T08:54:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/21/fda-publish-cdhr-strategic-priorities/</loc>
		<lastmod>2010-12-20T08:51:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/20/nice-publish-guidance-on-endoscopic-submucosal-dissection-of-oesophageal-dysplasia-and-neoplasia/</loc>
		<lastmod>2010-12-20T08:42:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/20/nice-publish-guidance-on-services-to-pregnant-women-with-complex-social-factors/</loc>
		<lastmod>2010-12-20T08:42:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/18/fda-publish-guidance-on-typanosoma-cruzi-infection-from-blood/</loc>
		<lastmod>2010-12-14T10:04:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/17/mhra-open-consultation-of-nicorette-15mg-inhalator-p-to-gsl-switch/</loc>
		<lastmod>2010-12-14T09:59:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/16/mhra-publish-guidance-for-journalists-reporting-on-medicines/</loc>
		<lastmod>2010-12-14T09:52:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/15/fda-publish-guidance-on-open-public-hearings-at-fda-meetings/</loc>
		<lastmod>2010-12-14T09:42:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/14/fda-publish-recommendations-for-blood-establishments/</loc>
		<lastmod>2010-12-14T09:37:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/13/nice-publish-guidance-on-in-stent-coronary-restenosis/</loc>
		<lastmod>2010-12-06T10:55:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/12/ema-publish-concept-paper-on-palatability-of-veterinary-medical-products/</loc>
		<lastmod>2010-12-06T10:50:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/11/ema-guidance-on-single-enantiomers-as-nces/</loc>
		<lastmod>2010-12-06T10:46:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/10/ema-publish-concept-paper-on-storage-conditions-during-transport/</loc>
		<lastmod>2010-12-06T10:36:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/09/ema-publishes-concept-paper-on-revision-of-eu-qc-gmp-guide/</loc>
		<lastmod>2010-12-06T10:32:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/08/ema-publish-guideline-on-biological-similar-monoclonal-antibodies/</loc>
		<lastmod>2010-12-06T10:28:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/07/ema-publish-guideline-on-immunogenicity-assessment-of-monoclonals/</loc>
		<lastmod>2010-12-06T10:23:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/06/ema-hold-joint-topraema-meeting-review-of-the-year-and-outlook-today/</loc>
		<lastmod>2010-12-06T09:42:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/08/ema-announces-global-animal-health-conference/</loc>
		<lastmod>2010-11-30T16:21:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/07/ema-announces-second-int-symposium-in-biopharmaceutical-statistics/</loc>
		<lastmod>2010-11-30T16:18:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/06/ema-publishes-references-for-yarrow-flower-assessment/</loc>
		<lastmod>2010-11-30T16:14:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/06/ema-publish-references-for-achillea-millefolium-l-herba-assessment/</loc>
		<lastmod>2010-11-30T16:11:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/05/ema-publishes-assessment-report-on-achillea-millefolium-l-flos/</loc>
		<lastmod>2010-11-30T16:08:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/04/ema-publish-assessment-report-on-achillea-millefolium-l-herba/</loc>
		<lastmod>2010-11-30T16:04:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/03/ema-publish-references-for-gummi-resina-assessment/</loc>
		<lastmod>2010-11-30T16:01:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/02/ema-publish-assessment-on-gummi-resina/</loc>
		<lastmod>2010-11-30T15:59:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/01/fda-publish-guidance-on-performance-of-clostridium-difficile-diagnostics/</loc>
		<lastmod>2010-11-30T15:55:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/09/fda-publish-guidance-on-blood-lancet-labeling/</loc>
		<lastmod>2010-11-30T15:52:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/08/fda-publishes-guidance-on-andas-and-impurities/</loc>
		<lastmod>2010-11-30T15:42:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/07/fda-publishes-guidance-on-developing-drugs-for-hospital-acquired-pneumonia/</loc>
		<lastmod>2010-11-30T13:43:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/06/fda-publishes-guidance-on-antibacterial-drug-approval/</loc>
		<lastmod>2010-11-30T13:38:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/05/nice-publish-guidance-on-uterine-artery-embolisation-for-fibroids/</loc>
		<lastmod>2010-11-30T13:34:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/04/nice-publish-guidance-on-radiation-therapy-in-dupuytrens/</loc>
		<lastmod>2010-11-30T13:29:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/03/nice-publish-guidance-on-non-rigid-stabilisation/</loc>
		<lastmod>2010-11-30T13:24:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/02/nice-publish-guidance-on-interspinous-distraction/</loc>
		<lastmod>2010-11-30T13:20:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/01/nice-publish-tech-appraisal-imatinib-in-gastric-cancer/</loc>
		<lastmod>2010-11-30T10:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/30/nice-publishes-guidance-on-trastuzumab-for-gastric-cancer/</loc>
		<lastmod>2010-11-30T10:10:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/29/fda-publish-guidance-on-communication-of-safety-information/</loc>
		<lastmod>2010-11-25T10:11:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/28/mhra-start-consultation-for-ibuprofen-p-to-gsl-switch/</loc>
		<lastmod>2010-11-25T10:07:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/27/fda-publish-drug-safety-update-for-osteoperosis-drugs-and-fractures/</loc>
		<lastmod>2010-11-25T10:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/26/ema-pubishes-guideline-on-epidemiological-data-on-blood-transmissible-infections/</loc>
		<lastmod>2010-11-25T09:56:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/30/ema-publish-guidance-on-iv-products-in-micellar-systems/</loc>
		<lastmod>2010-11-25T09:49:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/29/ema-publish-ich-e3f-development-safety-update-reporting/</loc>
		<lastmod>2010-11-25T09:45:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/28/ema-publish-qa-on-the-guideline-on-limits-of-genotox-impurities/</loc>
		<lastmod>2010-11-25T09:40:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/27/ema-publish-draft-revision-of-qrd-annotated-veterinary-template/</loc>
		<lastmod>2010-11-25T09:36:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/26/ema-publish-qa-on-post-approval-change-management-protocols/</loc>
		<lastmod>2010-11-25T09:32:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/25/ema-publish-guide-for-early-phases-of-orphan-applications/</loc>
		<lastmod>2010-11-24T10:24:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/25/ema-publish-implementation-plan-for-eudravigilance-human-safety-reporting/</loc>
		<lastmod>2010-11-24T10:17:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/24/ema-publish-draft-recommendations-on-dossiers-for-combination-products/</loc>
		<lastmod>2010-11-24T10:13:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/24/ema-publish-guideline-for-e-submission-of-parallel-distribution-notification/</loc>
		<lastmod>2010-11-24T10:09:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/22/ema-publish-guidane-on-post-authorisation-procedural-adivice-for-human-medicinal-products/</loc>
		<lastmod>2010-11-15T10:01:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/22/ema-announce-eudravigilance-information-day/</loc>
		<lastmod>2010-11-15T09:56:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/21/ema-publish-draft-reflection-paper-on-iv-micellar-systems/</loc>
		<lastmod>2010-11-15T09:51:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/20/ema-announces-workshop-on-paediatric-formulations-for-assessors/</loc>
		<lastmod>2010-11-15T09:47:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/19/ema-announce-second-diaema-innovation-forum/</loc>
		<lastmod>2010-11-15T09:45:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/18/ema-announce-topraema-annual-european-medicines-agency-review/</loc>
		<lastmod>2010-11-15T09:42:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/17/ema-announce-expert-meeting-familial-neurodegenerative-disorders/</loc>
		<lastmod>2010-11-15T09:37:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/16/ema-call-for-submissions-on-uncaria-tomentosa-cats-claw/</loc>
		<lastmod>2010-11-15T09:33:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/15/mhra-starts-public-consultation-on-podiatrists-prescribing/</loc>
		<lastmod>2010-11-15T09:26:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/14/mhra-review-medicines-legislation-patient-group-directions/</loc>
		<lastmod>2010-11-09T09:59:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/13/fda-guidance-cellular-therapy-for-cardiac-disease/</loc>
		<lastmod>2010-11-09T09:55:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/12/fda-guidance-assay-for-immunogenicity-testing-of-proteins/</loc>
		<lastmod>2010-11-09T09:50:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/11/fda-lists-guidance-documents-for-2011-development/</loc>
		<lastmod>2010-11-09T09:47:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/10/fda-guidance-urls-on-electronic-product-labeling/</loc>
		<lastmod>2010-11-09T09:43:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/09/fda-workshop-innovations-in-diabetes-artifical-pancrease/</loc>
		<lastmod>2010-11-09T09:39:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/07/nice-terminates-appraisal-on-temsirolimus-in-mantle-cell-lymphoma/</loc>
		<lastmod>2010-11-03T10:01:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/06/nice-publish-guidance-on-bendamustine-in-non-hodgkins-lymphoma/</loc>
		<lastmod>2010-11-03T09:50:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/05/nice-publish-guidance-on-transperineal-biopsy-mapping-of-prostate/</loc>
		<lastmod>2010-11-03T09:46:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/04/nice-publish-guidance-on-eltrombopag-for-chronic-immune-thrombocytopenic-purpura/</loc>
		<lastmod>2010-11-03T09:41:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/03/nice-publish-guidance-on-percutaneous-posterior-tibial-nerve-stimulation-for-overactive-bladder-syndrome/</loc>
		<lastmod>2010-11-03T09:37:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/10/nice-publish-appraisal-of-denosumab-for-osteoporotic-fractures/</loc>
		<lastmod>2010-11-02T10:02:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/09/nice-publish-guidance-on-nocturnal-enuresis-bedwetting/</loc>
		<lastmod>2010-11-02T09:57:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/08/nice-publish-guidance-on-total-hip-replacement/</loc>
		<lastmod>2010-11-02T09:53:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/07/nice-publish-appraisal-for-liraglutide-in-type-2-diabetes/</loc>
		<lastmod>2010-11-02T09:50:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/06/nice-publish-appraisal-for-omalizumab-in-allergic-asthma/</loc>
		<lastmod>2010-11-02T09:46:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/05/nice-publish-appraisal-on-ofatumumab-for-leukaemia/</loc>
		<lastmod>2010-11-02T09:42:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/04/nice-publish-guidance-on-endoscopic-mucosal-resection/</loc>
		<lastmod>2010-11-02T09:38:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/03/nice-publish-guidance-on-endoscopic-dissection-of-gastric-lesions/</loc>
		<lastmod>2010-11-02T09:10:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/medqp/report-3-review-fda-m3r2-guidance/</loc>
		<lastmod>2010-11-02T09:05:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/02/nice-publish-guidance-on-metal-rib-reinforcements/</loc>
		<lastmod>2010-11-02T09:03:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/testimonials/</loc>
		<lastmod>2010-10-26T10:11:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/30/testimonial-alan-ezrin-nxpharmagen/</loc>
		<lastmod>2010-10-26T10:08:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/29/fda-publish-guidance-on-qualification-for-drug-development-tools/</loc>
		<lastmod>2010-10-26T10:05:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/28/fda-publish-guidance-on-humanitarian-device-exemptions-hde/</loc>
		<lastmod>2010-10-26T10:01:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/27/fda-publish-guidance-on-human-studies-without-an-ind/</loc>
		<lastmod>2010-10-25T14:05:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/26/mhra-announce-review-of-medicines-legislation-with-regard-to-informal-consultations/</loc>
		<lastmod>2010-10-25T13:59:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/25/ema-publish-guideline-on-clinical-studies-in-copd/</loc>
		<lastmod>2010-10-25T13:55:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/31/ema-publish-adendum-on-antiarrhythmics-on-atrial-fibrilation-and-atrial-flutter/</loc>
		<lastmod>2010-10-25T13:51:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/30/ema-publish-guidance-on-missing-data-from-confirmatory-clinical-trials/</loc>
		<lastmod>2010-10-25T13:47:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/29/ema-publish-ich-e2f-guideline-on-development-safety-update-reporting/</loc>
		<lastmod>2010-10-25T13:43:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/28/ema-publish-ich-q4b-guidlines-on-bulk-density-and-tapped-density-of-powders/</loc>
		<lastmod>2010-10-25T13:38:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/27/ema-publish-ich-q4b-guidance-on-analytical-sieving/</loc>
		<lastmod>2010-10-25T13:34:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/26/ema-publish-ich-q4b-guidlines-on-capilllary-electrophoresis/</loc>
		<lastmod>2010-10-25T13:31:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/25/ema-publish-ich-m2-guideline-busines-requirements/</loc>
		<lastmod>2010-10-25T13:27:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/27/ema-ich-e16-genomic-biomarkers-related-to-drug-response/</loc>
		<lastmod>2010-10-18T09:13:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/26/ema-ich-q4b-bacterial-endotoxins/</loc>
		<lastmod>2010-10-18T08:54:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/25/ema-vich-data-elements-for-submission-of-adverse-event-reports-aers/</loc>
		<lastmod>2010-10-18T08:50:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/24/ema-vich-guideline-on-controlled-list-of-terms/</loc>
		<lastmod>2010-10-18T08:47:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/23/ema-guideline-on-pharmacovigilance-of-veterinary-medicinal-products/</loc>
		<lastmod>2010-10-18T08:42:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/22/ema-reflection-paper-on-meticillin-resistant-staph-pseudintermedius/</loc>
		<lastmod>2010-10-18T08:38:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/21/ema-concept-paper-on-efficacy-studies-in-nsaids/</loc>
		<lastmod>2010-10-18T08:34:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/20/ema-publish-roles-and-responsibilities-for-the-paediatric-committee-pdco/</loc>
		<lastmod>2010-10-18T08:25:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/19/ema-concept-paper-on-the-evaluation-of-anticancer-medicinal-products/</loc>
		<lastmod>2010-10-18T08:21:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/18/ema-publish-concept-paper-on-renal-insufficiency-clinical-trials/</loc>
		<lastmod>2010-10-18T08:15:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/13/new-fda-draft-guidance-safety-reporting-for-inds/</loc>
		<lastmod>2010-10-13T14:12:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/17/ema-reflection-paper-labs-that-perform-clinical-trials-analysis/</loc>
		<lastmod>2010-10-13T13:58:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/16/ema-draft-guidance-on-statistical-principles-for-veterinary-clinical-trials/</loc>
		<lastmod>2010-10-13T13:53:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/16/ema-concept-paper-on-conduct-of-efficacy-studies-for-intramammary-products-in-cattle/</loc>
		<lastmod>2010-10-13T12:01:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/15/fda-draft-guidance-on-herpes-simplex-virus-types-1-and-2-serological-assays/</loc>
		<lastmod>2010-10-13T11:58:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/14/new-fda-draft-guidance-performance-criteria-for-in-vitro-diagnostics-h-pylori/</loc>
		<lastmod>2010-10-13T11:53:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/10/fda-publishes-guidance-for-its-staff-the-leverage-handbook-effecive-collaborations/</loc>
		<lastmod>2010-09-29T08:47:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/08/nice-publish-guidance-on-phototherapeutic-laser-keratectomy-for-corneal-surface-irregularities/</loc>
		<lastmod>2010-09-29T08:37:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/07/nice-publish-guidance-on-percutaneous-intradiscal-laser-ablation-in-lumbar-spine/</loc>
		<lastmod>2010-09-29T08:33:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/06/nice-publish-guidance-on-laproscopic-hysterectomy-for-endometrial-cancer/</loc>
		<lastmod>2010-09-29T08:29:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/05/nice-publish-technology-review-on-peginterferon-alfa-and-ribavirin-for-hepc/</loc>
		<lastmod>2010-09-29T08:19:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/03/fda-publishes-qa-on-humanitarian-device-exemption-hde-regulation/</loc>
		<lastmod>2010-09-29T08:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/02/mhra-publishes-draft-guidance-on-vigilance-systems-for-joint-replacement-implants/</loc>
		<lastmod>2010-09-29T07:53:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/01/ema-publish-guideline-on-clinical-investigations-of-epileptic-disorders/</loc>
		<lastmod>2010-09-29T07:47:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/30/ema-announce-international-workshop-on-the-ethical-and-good-clinical-practice-gcp-aspects-of-clinical-trials-conducted-in-third-countries/</loc>
		<lastmod>2010-09-29T07:42:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/29/ema-announce-workshop-on-nano-medicines/</loc>
		<lastmod>2010-09-29T07:35:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/26/twitter-weekly-updates-for-2010-09-26/</loc>
		<lastmod>2010-09-26T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/26/ema-publishes-assessment-report-on-valeriana-officinalis-l-radix-and-humulus-lupulus-l-flos/</loc>
		<lastmod>2010-09-20T09:26:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/25/ema-publiushes-overview-of-comments-received-on-community-herbal-monograph-on-valeriana-officinalis-l-radix-and-humulus-lupulus-l-flos-emahmpc1320772010/</loc>
		<lastmod>2010-09-20T09:22:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/24/ema-publish-opinion-on-community-herbal-monograph-on-valeriana-officinalis-l-radix-and-humulus-lupulus-l-flos/</loc>
		<lastmod>2010-09-20T09:18:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/23/ema-publish-list-of-references-supporting-the-assessment-of-valeriana-officinalis-l-radix-and-humulus-lupulus-l-flos/</loc>
		<lastmod>2010-09-20T09:13:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/22/fda-publishes-guidance-on-class-ii-special-controls-for-certain-percutaneous-transluminal-coronary-angioplasty-pcta-catheters/</loc>
		<lastmod>2010-09-20T09:08:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/21/fda-publishes-guidance-on-chronic-hepatitis-c-virus-infection-developing-direct-acting-antiviral-agents-for-treatment/</loc>
		<lastmod>2010-09-20T09:04:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/20/fda-publishes-guidnace-on-suicidality-prospective-assessment-of-accurance-in-clinical-trials/</loc>
		<lastmod>2010-09-20T08:59:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/13/ema-the-european-drug-regulators-publish-qas-on-the-withdrawl-of-the-note-for-guidance-on-single-dose-toxicity/</loc>
		<lastmod>2010-09-08T11:01:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/23/fda-puiblish-guidance-on-q4b-evaluation-and-recommendation-of-pharmacopoeial-text-for-use-in-ich-regions-annex-12-analytical-sieving-general-chapter/</loc>
		<lastmod>2010-09-07T11:49:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/22/fda-publish-q4b-evaluation-and-recommendation-of-pharmacopoeial-texts-for-use-in-ich-regions-annex-11-capillary-electrophoresis-general-chapter/</loc>
		<lastmod>2010-09-07T11:45:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/21/fda-publish-guidance-on-developing-drugs-for-acute-bacterial-skin-and-skin-structure-infections/</loc>
		<lastmod>2010-09-07T11:40:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/20/mhra-start-consultation-to-allow-student-midwives-access-to-the-parenteral-medicines-which-can-be-administered-by-registered-midwives/</loc>
		<lastmod>2010-09-07T11:35:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/19/nice-publish-guidance-on-tocilizumab-for-the-treatment-of-rheumatoid-arthritis/</loc>
		<lastmod>2010-09-07T11:31:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/18/nice-publish-guidance-on-the-mangement-of-transient-loss-of-consiousness-blackouts-in-adults-and-young-people/</loc>
		<lastmod>2010-09-07T11:06:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/17/nice-publish-guidlines-on-the-management-of-hypertensive-disorders-during-pregnancy/</loc>
		<lastmod>2010-09-07T11:00:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/16/nice-publish-guidance-on-adalimumab-etanercept-infliximab-rituximab-and-adataqcept-for-the-treatment-of-rheumatoid-arthritis-after-failure-of-a-tnf-inhibitor/</loc>
		<lastmod>2010-09-07T10:51:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/15/nice-publishes-guidance-on-etanercept-infliximab-and-adalimumab-for-the-treatment-of-psoriatic-arthritis/</loc>
		<lastmod>2010-09-06T15:35:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/14/nice-publish-guidance-on-imatinib-for-the-adjutant-treatment-of-gastrointestinal-stromal-tumours/</loc>
		<lastmod>2010-09-06T15:30:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/13/nice-publish-national-clinical-guideline-for-diagnosis-and-management-of-chronic-heart-failure-in-primary-and-secondary-care/</loc>
		<lastmod>2010-09-06T15:26:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/12/nice-publish-guidance-on-dronedarone-for-the-treatment-of-non-permanent-atrial-fibrillation/</loc>
		<lastmod>2010-09-06T15:21:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/11/fda-publish-guidance-on-animal-studies-for-cardiovascular-disease/</loc>
		<lastmod>2010-09-06T15:17:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/10/fda-publishes-summary-of-safety-and-effectivenss-data-ssed-clinical-section-checklist-office-of-device-evaluation/</loc>
		<lastmod>2010-09-06T15:13:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/09/fda-announces-grant-funding-for-safety-and-effectivenss-of-orphan-products-rsearch-project-grant-r01/</loc>
		<lastmod>2010-09-06T15:05:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/08/fda-announce-public-workshop-optimizing-clinical-trial-deisngs-for-pedatric-cardiovascaulr-devices/</loc>
		<lastmod>2010-09-06T14:56:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/07/fda-publish-guidance-on-the-non-clincal-and-clinical-investigations-of-devices-for-the-treatment-of-benign-prostatic-hyperplasia-bhp/</loc>
		<lastmod>2010-09-06T14:49:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/06/fda-publish-guidance-on-contact-lens-care-products-labeling/</loc>
		<lastmod>2010-09-06T14:43:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/19/ema-publishes-guidance-on-centrally-authorised-products-requiring-a-notification-of-a-change-for-update-of-annexes/</loc>
		<lastmod>2010-09-03T14:59:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/18/ema-publish-guideline-for-the-specifications-of-e-submissions-of-parallel-distribution-notification-documents/</loc>
		<lastmod>2010-09-03T14:56:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/17/ema-publishes-community-herbal-monograph-on-cinnamomum-verum-j-s-presl-cinnamomum-zeylanicum-nees-aetheroleum/</loc>
		<lastmod>2010-09-03T14:51:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/16/ema-publishes-community-herbal-monograph-on-arctostaphylos-uva-ursi-l-spreng-folium/</loc>
		<lastmod>2010-09-03T14:47:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/16/ema-announce-tenth-ema-human-scientific-committees-working-party-with-patients-and-consumers-organisations-pcwp-meeting/</loc>
		<lastmod>2010-09-03T14:42:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/15/ema-announce-first-joint-diaema-workshop-on-statistical-methodology-in-clinical-rd/</loc>
		<lastmod>2010-09-03T14:39:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/14/ema-publishes-assessment-report-on-cinnamomum-verum-j-s-presl-cinnamomum-zeylanicum-nees-cortex-and-corticis-aetheroleum/</loc>
		<lastmod>2010-09-03T14:35:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/14/ema-publish-list-of-references-supporting-the-assessment-of-cinnamomum-verum-j-s-presl-cinnamomum-zeylanicum-nees-cortex-and-corticis-aetheroleum/</loc>
		<lastmod>2010-09-03T14:32:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/13/ema-pubish-community-herbal-monograph-on-cinnamomum-verum-j-s-presl-cinnamomum-zeylanicum-nees-cortex/</loc>
		<lastmod>2010-09-03T14:27:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/12/ema-publish-community-herbal-monograph-on-cinnamomum-verum-j-s-presl-cinnamomum-zeylanicum-nees-aetheroleum/</loc>
		<lastmod>2010-09-03T14:23:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/11/ema-publish-list-of-references-supporting-the-assessment-of-arctostaphylos-uva-ursi-l-spreng-folium/</loc>
		<lastmod>2010-09-03T14:19:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/10/ema-publish-community-herbal-monograph-on-arctostaphylos-uva-ursi-l-spreng-folium/</loc>
		<lastmod>2010-09-03T14:11:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/09/ema-publish-assessment-report-on-arctostaphylos-uva-ursil-spreng-folium/</loc>
		<lastmod>2010-09-03T14:08:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/08/fda-publishes-guidance-on-organ-specific-warnings-internal-analgesic-antipyretic-and-antirheumatic-drug-products-for-over-the-counter-human-use-small-entity-compliance-guide/</loc>
		<lastmod>2010-09-01T09:54:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/07/nice-publishes-guidance-on-ablative-therapy-for-the-treatment-of-barretts-oesophagus/</loc>
		<lastmod>2010-09-01T09:49:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/06/fda-publishes-guidance-on-label-comprehension-studies-for-non-prescription-drug-products/</loc>
		<lastmod>2010-09-01T09:45:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/05/ema-publishes-guidline-on-quality-non-clinical-and-clinical-aspects-of-live-recombinant-viral-vectored-vaccines/</loc>
		<lastmod>2010-09-01T09:40:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/04/ema-publish-reflection-paper-on-electronic-source-data-and-collection-tools-in-clinical-trials/</loc>
		<lastmod>2010-09-01T09:36:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/03/ema-to-have-debate-on-the-use-of-epidemiology-in-the-assessment-of-drug-effects/</loc>
		<lastmod>2010-09-01T09:32:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/02/ema-and-fda-seek-candidate-for-joint-gmp-inspection-programme/</loc>
		<lastmod>2010-09-01T09:29:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/01/the-fda-issues-assessments-of-the-510k-programme-and-use-of-science-in-decision-making/</loc>
		<lastmod>2010-09-01T09:25:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/31/testimonial-skinsecure-joanne-reed/</loc>
		<lastmod>2010-08-23T09:49:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/30/nice-the-uk-hmo-publishes-full-guidance-on-the-diagnosis-and-management-of-metastatic-malignant-disease-of-unknown-primary-origin/</loc>
		<lastmod>2010-08-23T09:46:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/29/nice-the-uk-hmo-publishes-guidance-on-dietary-interventions-and-physical-activity-interventions-for-weight-management-before-during-and-after-pregnancy/</loc>
		<lastmod>2010-08-23T09:38:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/28/nice-the-uk-hmo-publishes-guidance-on-percutaneous-radiofrequency-ablation-for-renal-cancer/</loc>
		<lastmod>2010-08-23T09:31:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/27/nice-the-uk-hmo-publishes-guidance-on-percutaneous-mitral-valve-annuloplasty-2/</loc>
		<lastmod>2010-08-23T09:28:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/26/nice-the-uk-hmo-publishes-guidance-on-motor-neurone-disease-the-use-of-non-invasive-ventilation/</loc>
		<lastmod>2010-08-23T09:23:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/25/nice-the-uk-regulator-publishes-guidance-on-rituximab-for-the-treatment-of-relapsed-or-refractory-chronic-lymphocytic-leukaemia/</loc>
		<lastmod>2010-08-23T09:19:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/24/nice-the-uk-hmo-published-guidance-on-delirium-diagnosis-prevention-and-management/</loc>
		<lastmod>2010-08-19T12:49:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/23/nice-the-uk-hmo-publish-guidance-on-capecitabine-for-the-treatment-of-advanced-gastric-cancer/</loc>
		<lastmod>2010-08-19T12:44:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/26/nice-the-uk-hmo-published-guidance-on-denosumab-for-the-treatment-of-therapy-induced-bone-loss-in-non-metastatic-prostate-cancer-terminated-appraisal/</loc>
		<lastmod>2010-08-17T07:59:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/25/fda-the-usa-drug-regulator-published-guidance-for-industry-on-label-comprehension-studies-for-non-prescription-drug-products/</loc>
		<lastmod>2010-08-17T07:55:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/24/ema-the-european-drug-regulator-published-a-draft-chmp-position-statement-on-creutzfeldt-jakob-disease-and-plasma-dervied-and-urine-dervied-medical-products/</loc>
		<lastmod>2010-08-17T07:52:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/23/ema-the-european-drug-regulatory-published-a-draft-chmpcat-position-statement-on-creutzfeldt-jakob-disease-and-advanced-therpay-medical-products/</loc>
		<lastmod>2010-08-17T07:48:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/22/the-ema-the-european-drug-regulator-published-comments-received-on-guideline-on-clinical-investigation-of-medicinal-products-in-the-treatment-of-epileptic-disorders/</loc>
		<lastmod>2010-08-17T07:44:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/21/the-ema-the-european-drug-regulator-published-qa-on-ich-topic-e7-studies-in-support-of-special-populations-geriatrics-step-5/</loc>
		<lastmod>2010-08-17T07:39:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/20/ema-the-european-drug-regulator-published-draft-guidance-on-setting-specifications-for-related-impurities-in-antibiotics/</loc>
		<lastmod>2010-08-17T07:34:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/19/ema-the-european-drug-regulator-published-a-concept-paper-on-the-revision-of-the-note-for-guidance-on-quality-of-modified-release-oral-dosage-forms-and-transdermal-dosage-forms-section-i-quality/</loc>
		<lastmod>2010-08-17T07:31:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/18/ema-the-european-drug-regulator-publish-guideline-on-the-clinical-investigation-of-human-normal-immunoglobulin-for-intravenous-administration-ivig/</loc>
		<lastmod>2010-08-17T07:26:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/17/ema-the-european-regulator-publishes-overview-of-comments-received-on-the-guideline-on-the-clinical-investigation-of-human-normal-immunoglobulin-for-intravenous-administration-ivig/</loc>
		<lastmod>2010-08-17T07:21:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/31/ema-the-european-drug-regulator-publishes-chmp-efficacy-working-party-therapeutic-subgroup-on-pharmacokinetics-ewp-pk-qa-on-positions-on-specific-questions-addressed/</loc>
		<lastmod>2010-08-12T15:02:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/30/ema-the-european-drug-regulator-publish-overview-of-comments-received-on-guideline-on-the-clinical-investigation-of-medicinal-products-for-the-treatment-of-attention-deficit-hyperactivity-disorder/</loc>
		<lastmod>2010-08-12T14:57:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/29/ema-publishes-guidance-on-the-clinical-investigation-of-medicinal-products-for-the-treatment-of-attention-deficit-hyperactivity-disorder-adhd/</loc>
		<lastmod>2010-08-12T14:53:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/28/ema-the-european-drug-regulatory-publishes-draft-procedural-advice-on-the-consultation-of/</loc>
		<lastmod>2010-08-12T14:48:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/regulatory-services/</loc>
		<lastmod>2010-08-12T14:46:28+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/27/ema-the-european-drug-regulator-publishes-centralised-procedures-and-mrl-procedures-recommended-submission-dates-for-new-and-extension-applications/</loc>
		<lastmod>2010-08-12T14:39:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/26/ema-the-european-drug-regulator-publishes-concept-paper-on-the-revision-of-the-note-for-guidance-on-the-quality-of-modified-release-oral-dosage-forms-and-transdermal-dosage-forms-section-i-quality/</loc>
		<lastmod>2010-08-12T14:35:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/25/ema-the-european-drug-regulator-publishes-draft-guideline-on-setting-specifications-for-related-impurities-in-antibiotics/</loc>
		<lastmod>2010-08-12T14:31:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/24/ema-the-european-drug-regulatory-publish-draft-procedural-advice-on-the-consultation-of-notified-bodies-in-accordance-with-article-9-of-regulation-ec-no-13942007/</loc>
		<lastmod>2010-08-12T14:27:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/23/ema-the-european-drug-regulator-publish-draft-chmpcat-position-statement-on-creutzfeldt-jakob-disease-and-advanced-therapy-medicinal-products/</loc>
		<lastmod>2010-08-12T14:23:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/22/ema-the-european-drug-regulator-publishes-a-draft-chmp-position-statement-on-creutzfeldt-jakob-disease-and-plasma-derived-and-urine-derived-medicinal-products/</loc>
		<lastmod>2010-08-12T14:19:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/21/ema-the-european-drug-regulator-announce-encepp-information-day/</loc>
		<lastmod>2010-08-11T10:47:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/20/ema-the-european-drug-regulator-publishes-draft-guidance-on-setting-specifications-for-related-impurities-in-antibiotics/</loc>
		<lastmod>2010-08-11T10:42:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/19/ema-the-european-drug-regulator-publishes-a-concept-paper-on-the-revision-of-the-note-for-guidance-on-quality-or-modified-release-oral-dosage-forms-and-transdermal-dosage-forms-section-1-quality/</loc>
		<lastmod>2010-08-11T10:38:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/18/ema-the-european-drug-regulator-publishes-qa-on-quality-of-medicines/</loc>
		<lastmod>2010-08-11T10:33:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/17/ema-the-european-drug-regulatory-publish-qas-for-good-manufacturing-practice-gmp/</loc>
		<lastmod>2010-08-11T10:30:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/16/fda-the-usa-drug-regulator-publishes-guidance-on-residual-drug-in-transdermal-and-related-drug-delivery-systems/</loc>
		<lastmod>2010-08-11T10:26:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/16/nice-the-uk-hmo-publishes-guidance-for-densumab-for-the-treatment-of-therapy-induced-bone-loss-in-non-metastatic-prostate-cancer-terminated-appraisal/</loc>
		<lastmod>2010-08-11T10:22:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/15/nice-the-uk-hmo-publishes-guidance-on-gefitinib-for-the-first-line-treatment-of-locally-advanced-or-metastatic-non-small-cell-lung-cancer/</loc>
		<lastmod>2010-08-11T10:18:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/14/nice-the-uk-hmo-publishes-guidance-on-rituximab-for-the-treatment-of-relapsed-or-refractory-chronic-lymphocytic-leukaemia/</loc>
		<lastmod>2010-08-11T10:13:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/13/nice-the-uk-hmo-publishes-guidance-on-the-capecitabine-for-advanced-gastric-cancer/</loc>
		<lastmod>2010-08-11T10:08:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/12/nice-the-uk-hmo-publishes-guidance-on-delirium-diagnosis-prevention-and-management/</loc>
		<lastmod>2010-08-11T08:26:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/11/nice-the-uk-hmo-publish-guidance-on-the-use-of-non-invasive-ventilation-in-the-management-of-motor-neurone-disease/</loc>
		<lastmod>2010-08-11T08:20:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/11/fda-the-drug-regulator-publishes-the-act-improving-access-to-innovative-medical-therapies-sec7001/</loc>
		<lastmod>2010-08-10T10:58:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/29/recomendation-for-damien-bove/</loc>
		<lastmod>2010-08-09T15:49:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/19/nice-the-uk-hmo-publishes-guidance-on-percutaneous-mitral-valve-annuloplasty/</loc>
		<lastmod>2010-08-02T14:07:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/18/fda-the-usa-drug-regulators-publish-guidance-for-industry-and-researchers-the-radioactive-drug-research-committee-human-research-without-an-investigational-new-drug-application/</loc>
		<lastmod>2010-08-02T14:01:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/17/the-medicines-for-human-use-advanced-therpay-medicinal-products-and-miscellaneous-amendments-regulations-2010-put-before-uk-parliament/</loc>
		<lastmod>2010-08-02T13:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/16/mhra-the-uk-drug-regulator-pubilshes-guidance-for-manufactures-on-clinical-investigations-to-be-carried-out-in-the-uk/</loc>
		<lastmod>2010-08-02T13:54:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/15/michael-j-fox-foundation-commits-up-to-us12-million-for-targeted-parkinsons-therapeutic-development-in-2011/</loc>
		<lastmod>2010-08-02T13:49:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/14/ema-the-european-drug-regulator-publishes-reflection-paper-on-non-clinical-evaluation-of-drug-induced-liver-injury-dili/</loc>
		<lastmod>2010-08-02T13:45:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/12/ema-the-european-drug-regulator-publishes-guidance-for-companies-requesting-scientific-advice-and-protocol-assistance/</loc>
		<lastmod>2010-08-02T13:38:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/11/ema-the-european-drug-regualtor-publishes-member-states-contact-points-for-translations-review/</loc>
		<lastmod>2010-08-02T13:33:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/10/ema-the-european-drug-regulator-publishes-qas-on-guidline-on-the-environmental-risk-assessment-of-medicinal-products-for-human-use/</loc>
		<lastmod>2010-08-02T13:27:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/09/ema-the-european-drug-regulator-publishes-concept-paper-on-assessment-of-persistent-bioaccumulative-and-toxic-pbt-or-very-persistent-and-very-bioaccumulative-vpvb-substances-in-veterinary-medicin/</loc>
		<lastmod>2010-08-02T13:17:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/08/ema-the-european-drug-regulatory-agency-publishes-questions-and-answers-on-the-note-for-guidance-on-photosafety-testing-draft/</loc>
		<lastmod>2010-08-02T13:13:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/07/ema-the-european-drug-regulators-publish-draft-guidance-on-conduct-of-bioequivalence-studies-for-veterinary-medical-products/</loc>
		<lastmod>2010-08-02T13:11:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/06/ema-the-european-drug-regulator-publishes-draft-guideline-on-demonstration-of-target-animal-safety-and-efficacy-of-veterinary-medical-products-intended-for-use-in-farmed-fish/</loc>
		<lastmod>2010-08-02T13:06:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/05/ema-the-european-drug-regualtor-publishes-draft-reflection-paper-on-ethical-and-gcp-aspects-of-clinical-trial-of-medical-products-for-human-use-conducted-in-third-countries-and-submitted-in-marketin/</loc>
		<lastmod>2010-08-02T13:03:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/04/ema-the-european-drug-regulator-publishes-standard-operating-procedure-for-request-for-fee-reduction-under-paragraph-1-of-article-9-of-council-regulation-ec-no29795/</loc>
		<lastmod>2010-08-02T12:56:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/03/nice-the-uk-hmo-publishes-clinical-guideline-on-diagnosis-and-management-of-metastatic-malignant-disease-of-unknown-primary-origin/</loc>
		<lastmod>2010-08-02T12:52:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/02/projects-from-yef-published/</loc>
		<lastmod>2010-08-02T12:45:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/01/twitter-weekly-updates-for-2010-08-01/</loc>
		<lastmod>2010-08-01T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/medqp/yorkshire-cancer-research-interview-with-mark-stevens-ceo/</loc>
		<lastmod>2010-07-28T08:41:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/28/fda-the-usa-drug-regulatory-publishes-draft-recommendation-for-the-revision-of-the-permitted-daily-exposure-for-cumene-according-to-the-maintenance-procedures-for-q3c-impurities-residual-solvents/</loc>
		<lastmod>2010-07-26T09:39:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/27/fda-the-usa-drug-regulator-published-q4b-evaluation-of-pharmacopoeial-texts-for-use-in-the-ich-regions-annex-14-bacterial-endotoxins-text-general-chapter/</loc>
		<lastmod>2010-07-26T09:34:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/26/the-mhra-the-uk-drug-regulators-published-a-reminder-update-to-labelling-to-comply-with-article-54a-54e-and-56a/</loc>
		<lastmod>2010-07-26T09:14:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/25/twitter-weekly-updates-for-2010-07-25/</loc>
		<lastmod>2010-07-25T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/18/ema-the-european-drug-regulator-publishes-comments-received-on-reflection-paper-on-quality-non-clinical-and-clinical-issues-related-to-development-of-recombinant-adeno-associated-viral-vectors/</loc>
		<lastmod>2010-07-22T15:44:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/19/ema-the-european-drug-regulator-publishes-reflection-paper-on-quality-non-clinical-and-clinical-issues-related-to-the-development-of-recombinant-adeno-associated-viral-vectors/</loc>
		<lastmod>2010-07-22T15:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/21/ema-the-eu-drug-regulator-published-draft-guidance-on-the-procedural-advices-on-the-submission-of-variations-for-annual-update-of-human-influenza-inactivated-vaccines-applications-in-the-centralised/</loc>
		<lastmod>2010-07-22T15:43:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/22/ema-the-european-drug-regulator-publishes-draft-guidance-on-ich-topic-q3c-r4-impurities-residual-solvents-pde-for-cumene/</loc>
		<lastmod>2010-07-22T15:41:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/23/ema-the-european-drug-regulator-published-draft-reflection-paper-on-the-co-development-of-pharmacogenomic-biomarkers-and-assays-in-the-context-of-drug-development/</loc>
		<lastmod>2010-07-22T15:40:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/24/market-report-on-life-sciences-and-healthcare-sector-forecasts/</loc>
		<lastmod>2010-07-22T15:40:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/25/ema-the-european-drug-regulators-publish-draft-guidance-on-non-clinical-and-clinical-aspects-of-medical-products-containing-geneticaly-modified-cells/</loc>
		<lastmod>2010-07-22T15:39:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/26/ema-the-european-drug-regulator-publishes-draft-guidance-on-detection-and-management-of-duplicate-individual-cases-and-individual-case-safety-reports-icsrs/</loc>
		<lastmod>2010-07-22T15:39:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/27/ema-the-eu-herbal-regulator-publishes-list-of-references-supporting-the-assessment-of-ribes-nigrum-l-folium-blackcurrant-leaf/</loc>
		<lastmod>2010-07-22T15:38:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/28/ema-the-european-herbal-regulatory-body-publishes-assessment-report-on-ribes-nigrum-l-folium-blackcurrant-leaf/</loc>
		<lastmod>2010-07-22T15:38:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/29/ema-the-european-herbal-regulator-publishes-overview-of-comments-received-on-community-herbal-monograph-on-ribes-nigrum-l-folium-blackcurrant-leaf/</loc>
		<lastmod>2010-07-22T15:38:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/30/ema-the-european-herbal-regulator-publishes-assessment-report-on-trigonella-foenum-graecum-l-semen-fenugreek-seed/</loc>
		<lastmod>2010-07-22T15:37:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/31/ema-the-european-herbal-regulator-publishes-assessment-report-on-leonurus-cardiaca-l-herba-motherwort/</loc>
		<lastmod>2010-07-22T15:36:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/19/mhra-the-uk-regulators-publish-guidance-on-the-vigilance-system-for-ce-marked-medical-devices-cardiac-ablation-catherters/</loc>
		<lastmod>2010-07-22T15:36:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/20/fda-the-us-drug-regulator-publishes-q4b-evaluation-and-recommendation-of-pharmacopoeial-texts-for-use-in-the-ich-regions-annex-13-bulk-density-and-tapped-density-of-powders-general-chapter/</loc>
		<lastmod>2010-07-22T15:33:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/pharmabiotech-development-services/</loc>
		<lastmod>2010-07-19T08:13:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/18/twitter-weekly-updates-for-2010-07-18/</loc>
		<lastmod>2010-07-18T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/17/ema-the-european-drug-regulator-published-a-draft-guidance-on-the-paediatric-addendum-to-chmp-note-for-guidance-on-clincial-investigation-of-medicinal-products-in-the-treatment-of-lipid-disorders/</loc>
		<lastmod>2010-07-12T08:17:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/16/ema-the-european-regulator-published-a-concept-paper-on-the-need-for-revision-of-the-note-for-guidance-on-modified-release-oral-and-transdermal-dosage-forms-section-ii-pk-and-clinical-evaluation/</loc>
		<lastmod>2010-07-12T08:11:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/15/fda-the-us-drug-regulator-reminder-of-tropical-disease-priority-review-vouchers/</loc>
		<lastmod>2010-07-12T08:06:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/14/new-oxford-fund-to-bridge-innovation-gap/</loc>
		<lastmod>2010-07-12T08:01:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/13/japanese-pharmaceuticals-and-medical-devices-agency-pmda-acceptance-of-kidney-health-biomarkers/</loc>
		<lastmod>2010-07-12T07:58:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/12/uk-government-to-set-up-regional-growth-fund/</loc>
		<lastmod>2010-07-12T07:54:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/11/twitter-weekly-updates-for-2010-07-11/</loc>
		<lastmod>2010-07-11T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/pharmabiotech-regulatory-services/</loc>
		<lastmod>2010-07-05T15:24:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/pharma-biotech-intellectual-property-cmc-services/</loc>
		<lastmod>2010-07-05T15:24:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/pharma-biotech-business-planning-services/</loc>
		<lastmod>2010-07-05T15:22:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/08/fda-the-us-drug-regulator-publish-faqs-on-in-vitro-diagnostic-device-studies/</loc>
		<lastmod>2010-07-05T08:55:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/07/fda-the-us-drug-regulator-publishes-draft-guidance-on-cmc-post-approval-manufacturing-changes-reportable-in-annual-reports/</loc>
		<lastmod>2010-07-05T08:50:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/06/fda-the-us-drug-regulator-publishes-guidance-on-developing-treatments-for-lupus-nephritis-caused-by-systemic-lupus-erthematosus/</loc>
		<lastmod>2010-07-05T08:45:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/05/fda-the-usa-drug-regulator-publishes-guidelines-on-developing-medical-products-for-the-treatment-of-systemic-lupus-erythematosus/</loc>
		<lastmod>2010-07-05T08:39:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/04/twitter-weekly-updates-for-2010-07-04/</loc>
		<lastmod>2010-07-04T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/12/ema-the-european-drug-regulator-publishes-draft-guideline-on-quality-non-clinical-and-clinical-aspects-of-medicinal-products-containing-genetically-modified-cells/</loc>
		<lastmod>2010-06-29T11:02:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/10/fda-the-drug-regulators-publish-implementation-of-the-biologicals-price-competition-and-innovation-act-2009/</loc>
		<lastmod>2010-06-29T11:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/09/nice-the-uk-hmo-publishes-guidance-on-how-to-stop-smoking-in-pregnancy-and-following-childbirth/</loc>
		<lastmod>2010-06-29T11:01:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/06/nice-the-uk-hmo-publishes-guidance-on-photodynamic-therapy-for-barretts-oesophagus/</loc>
		<lastmod>2010-06-29T11:01:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/05/nice-the-uk-mho-publishes-clinical-guidance-on-percutaneous-occlusion-of-the-left-atrial-appendage-in-non-valvular-atrial-fibrillation-for-the-prevention-of-thromboembolism/</loc>
		<lastmod>2010-06-29T11:00:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/08/yef-case-study-published-victoria-vinader-university-of-bradford/</loc>
		<lastmod>2010-06-29T08:49:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/07/nice-the-uk-hmo-publishes-clinical-guidance-on-staples-transanal-rectal-resection-for-obstructed-defaecation-syndrome/</loc>
		<lastmod>2010-06-29T08:43:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/04/nice-uk-hmo-publishes-updated-guidance-on-extracranial-to-intracranial-bypass-for-intracranial-atherosclerosis/</loc>
		<lastmod>2010-06-29T08:24:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/03/nice-the-uk-hmo-publishes-guidance-on-pemetrexed-for-the-maintenance-treatment-of-non-small-cell-lung-cancer/</loc>
		<lastmod>2010-06-29T08:05:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/02/nice-the-uk-hmo-updates-guidelines-on-chronic-obstructive-pulmonary-disease-management-of-chronic-obstructive-pulmonary-disease-in-adults-in-primary-and-secondary-care/</loc>
		<lastmod>2010-06-29T08:00:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/01/nice-the-uk-hmo-publish-treatment-guidlines-for-bacterial-menigitis-and-meningococcal-septicaemia/</loc>
		<lastmod>2010-06-29T07:55:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/30/nice-the-uk-hmo-publishes-public-health-guidance-on-prevention-of-cardiovascular-disease-at-population-level/</loc>
		<lastmod>2010-06-29T07:49:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/29/pfizer-gets-paid-for-running-a-phase-3-programme-we-can-all-do-this/</loc>
		<lastmod>2010-06-29T07:35:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/27/twitter-weekly-updates-for-2010-06-27/</loc>
		<lastmod>2010-06-27T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/25/device-regulatorsmhra-publishes-poster-magnetic-resonance-safety-top-tips/</loc>
		<lastmod>2010-06-21T09:05:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/24/drug-regulator-fda-guidance-on-in-vivo-bioavailablity-and-bioequivalence-studies-for-immediate-release-solid-oral-dosage-forms-based-on-biopharmaceutics-classification-system/</loc>
		<lastmod>2010-06-21T09:01:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/23/update-regulatory-service-offering/</loc>
		<lastmod>2010-06-21T08:57:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/22/hmo-nice-publishes-public-health-guidance-on-alcohol-use-disorders-preventing-the-development-of-hazardous-and-harmful-drinking/</loc>
		<lastmod>2010-06-21T08:52:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/21/open-access-therapeutic-drug-targets-database-launched/</loc>
		<lastmod>2010-06-21T08:47:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/19/drug-regulator-mhra-publishes-consultation-document-arm-67-regain-for-men-extra-strength-scalp-solution-5-wv-cutaneous-solution-request-to-reclassify-a-product-from-p-to-gsl/</loc>
		<lastmod>2010-06-14T08:54:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/18/drug-regulators-fda-publish-guidance-on-bioequivalence-recommendations-for-specific-products/</loc>
		<lastmod>2010-06-14T08:48:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/17/drug-regulators-ema-publish-a-concept-paper-on-the-need-for-revision-of-the-note-for-guidance-on-modified-release-oral-and-transdermal-dosage-forms-section-ii-pharmacokinetic-and-clinical-evaluati/</loc>
		<lastmod>2010-06-14T08:44:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/16/drug-regulators-ema-publish-draft-guidance-on-the-use-of-pharmacogenetic-methodologies-in-the-pharmacokinetic-evaluation-of-medicinal-products/</loc>
		<lastmod>2010-06-14T08:40:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/15/drug-regulator-ema-publish-concept-paper-on-the-need-for-revision-of-the-addendum-on-acute-cardiac-failure-of-the-note-for-guidance-on-clinical-investigation-of-medicinal-products-for-treatment-of-c/</loc>
		<lastmod>2010-06-14T08:32:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/14/bia-fund-map-useful-tool-for-finding-funding-for-your-technology-development/</loc>
		<lastmod>2010-06-14T08:19:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/13/twitter-weekly-updates-for-2010-06-13/</loc>
		<lastmod>2010-06-13T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/13/hmo-body-nice-publishes-guidance-on-alcohol-use-disorders-diagnosis-and-clinical-management-of-alcohol-related-physical-complications/</loc>
		<lastmod>2010-06-09T11:05:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/market-access-and-health-economics/</loc>
		<lastmod>2010-06-09T11:02:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/11/drug-regulator-fda-publish-faq-for-sponsors-clinical-investigators-and-irbs-on-statement-of-investigator-form-fda-1572/</loc>
		<lastmod>2010-06-08T09:48:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/10/drug-regulators-ema-emea-publish-concept-paper-on-need-for-revision-of-the-addendum-on-acute-cardiac-failure-of-the-note-for-guidance-on-clinical-investigation-of-medicinal-products-for-the-treatm/</loc>
		<lastmod>2010-06-08T09:46:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/12/drug-regulators-ema-emea-publish-draft-paediatric-addendum-to-chmp-guideline-on-the-clinical-investigations-of-medicinal-products-for-the-treatment-of-pulmonary-arterial-hypertension/</loc>
		<lastmod>2010-06-08T09:34:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/09/drug-regulator-ema-emea-publish-concept-paper-on-need-for-a-guideline-on-the-clinical-development-of-thrombopoetin-receptor-agonists-for-the-treatment-of-chronic-immune-idiopathic-thrombocytope/</loc>
		<lastmod>2010-06-08T08:52:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/08/drug-regulators-ema-emea-publish-draft-procedural-advice-on-the-submission-of-variations-for-annual-update-of-human-influenza-inactivated-vaccines-applications-in-the-centralised-procedure/</loc>
		<lastmod>2010-06-08T08:42:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/06/twitter-weekly-updates-for-2010-06-06/</loc>
		<lastmod>2010-06-06T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/ich-m3-consultancy-services-pre-clinical-consultancy/</loc>
		<lastmod>2010-06-03T15:08:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/03/19/new-microdosing-expolaratory-drug-studies-phase-i-clinical-trials/</loc>
		<lastmod>2010-06-03T15:00:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/08/rapid-drug-discovery-and-development-facilitated-by-ich/</loc>
		<lastmod>2010-06-03T14:59:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/13/drug-regulations-concept-paper-of-single-dose-acute-toxicity/</loc>
		<lastmod>2010-06-03T14:58:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/28/ich-m3-r2-non-clinical-safety-studies-guidance-updated-by-emea/</loc>
		<lastmod>2010-06-03T14:57:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/26/regulators-publish-guidance-for-industry-non-clinical-safety-studies-for-the-conduct-of-human-clinical-trials-and-marketing-authorization/</loc>
		<lastmod>2010-06-03T14:55:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/12/drug-regulators-ema-publish-draft-guidline-on-the-investigation-of-drug-interactions/</loc>
		<lastmod>2010-06-03T14:53:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/13/drug-regulator-ema-publishes-a-concept-paper-on-the-need-to-develop-an-appendix-to-the-guideline-on-bioequivalence-regarding-the-presentation-of-biopharmaceutical-and-bioanalytical-data-in-applicati/</loc>
		<lastmod>2010-06-03T14:52:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/29/drug-regulators-ema-emea-publish-draft-guidance-on-the-use-of-pharmacogenetic-methodologies-in-the-pharmacokinetic-evaluation-of-medicinal-products/</loc>
		<lastmod>2010-06-03T14:30:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/02/enzyme-reach-consortium-cost-sharing-policy/</loc>
		<lastmod>2010-06-03T14:28:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/07/drug-regulators-mhra-publish-revisions-to-the-medical-devices-and-active-implantable-medical-devices-directive/</loc>
		<lastmod>2010-06-01T14:03:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/06/drug-regulators-fda-publish-information-sheet-on-clinical-investigators-administrative-actions-and-disqualifications/</loc>
		<lastmod>2010-06-01T14:01:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/05/drug-regulator-ema-emea-publishes-draft-guideline-on-quality-aspects-on-the-isolation-of-candidate-influenza-vaccine-viruses-in-cell-culture/</loc>
		<lastmod>2010-06-01T13:54:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/04/drug-regulator-ema-emea-publishes-draft-guidance-on-treatment-of-premenstrual-dysphoric-disorder-pmdd/</loc>
		<lastmod>2010-06-01T13:48:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/03/drug-regulators-fda-publish-revised-preventative-measure-to-reduce-risk-of-transmission-of-creutzfeld-jakob-disease-and-variant-disease/</loc>
		<lastmod>2010-06-01T10:09:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/01/drug-regulator-mhra-publishes-guidance-on-website-advertising/</loc>
		<lastmod>2010-06-01T09:41:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/26/drug-regulators-fda-publish-q4b-evaluation-and-recommendation-of-pharmacopoeial-texts-for-use-in-the-ich-regions-annex-6-uniformity-of-dosage-unites-general-chapter/</loc>
		<lastmod>2010-05-25T12:20:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/25/testamonial-from-edinburgh-university/</loc>
		<lastmod>2010-05-25T06:46:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/30/drug-regulators-ema-emea-publish-reflection-paper-on-in-vitro-cultured-chondrocyte-containing-products-for-cartilage-repair-of-the-knee/</loc>
		<lastmod>2010-05-24T08:39:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/28/reminder-mhra-payment-easements-for-small-companies-definition-of-a-small-company/</loc>
		<lastmod>2010-05-24T08:28:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/27/drug-regulatorsfda-publish-ich-questions-and-answers-q8q9-and-q10/</loc>
		<lastmod>2010-05-24T08:23:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/24/drug-regulators-fda-publish-guidance-for-industry-nucleic-acid-testing-nat-for-human-immunodeficiency-virus-type-1-hiv-1-and-hepatitis-c-virus-hcv-testing-product-disposition-and-donor-def/</loc>
		<lastmod>2010-05-24T08:08:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/25/drug-regulators-fda-publish-guidance-on-requalification-method-for-reentry-of-blood-donors-deferred-because-of-reactive-test-results-for-antibody-to-hepatitis-b-core-antigen-anti-hbc/</loc>
		<lastmod>2010-05-24T08:07:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/23/twitter-weekly-updates-for-2010-05-23/</loc>
		<lastmod>2010-05-23T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/24/drug-regulators-fda-publish-guidance-on-requalification-method-for-reentry-of-blood-donors-deferred-because-of-reactive-test-results-for-antibody-to-hepatitis-b-core-antigen-anti-hbc-availability/</loc>
		<lastmod>2010-05-19T07:29:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/23/drug-regulators-fda-publish-guidance-for-public-fda-advisory-committee-members-and-fda-staff-on-public-availability-of-advisory-committee-members-financial-interest-information-and-waivers/</loc>
		<lastmod>2010-05-19T07:22:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/22/drug-regulators-fda-publish-draft-guidance-for-industy-and-fda-staff-on-user-fees-for-513g-requests-for-clasification-information/</loc>
		<lastmod>2010-05-19T07:16:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/21/drug-regulators-fda-publishes-draft-guidance-for-industry-and-fda-staff-on-procedures-for-section-513g-requests-for-information-under-the-federal-food-drug-and-cosmetic-act/</loc>
		<lastmod>2010-05-19T07:11:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/20/drug-regulators-ema-emea-publish-updated-guideline-on-declaration-of-herbal-substances-and-herbal-preparations-in-herbal-medicinal-products-traditional-herbal-medicinal-products/</loc>
		<lastmod>2010-05-19T07:01:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/19/drug-regulator-ema-emea-publish-comments-received-on-guideline-on-declaration-of-herbal-substances-and-herbal-preparations-in-herbal-medicinal-products-traditional-herbal-products/</loc>
		<lastmod>2010-05-19T06:54:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/18/drug-regulators-ema-publish-concept-paper-on-the-need-for-guideline-on-the-use-of-subgroup-analysis-in-randomised-controlled-trials/</loc>
		<lastmod>2010-05-12T07:22:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/17/drug-regulators-ema-publish-concept-paper-on-the-need-for-revision-of-the-notes-for-guidance-on-clinical-investigation-of-medicinal-products-in-the-treatment-of-schizophrenia-cpmpewp55995/</loc>
		<lastmod>2010-05-12T07:16:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/16/drug-regulators-ema-publish-overview-of-comments-received-on-guideline-on-the-clinical-evaluation-of-antifungal-agents-for-the-treatment-and-prophylaxis-of-invasive-fungal-disease/</loc>
		<lastmod>2010-05-12T07:10:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/15/drug-regulators-ema-publish-concept-paper-on-the-need-for-revision-of-the-guideline-on-the-clinical-development-of-medicinal-products-for-the-treatment-of-hepatitis-c/</loc>
		<lastmod>2010-05-12T07:05:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/14/drug-regulator-ema-publishes-concept-paper-on-the-need-for-revision-of-the-note-for-guidance-on-the-clinical-investigation-for-the-treatment-of-urinary-incontinence-cpmpewp1901/</loc>
		<lastmod>2010-05-12T06:58:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/09/twitter-weekly-updates-for-2010-05-09/</loc>
		<lastmod>2010-05-09T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/medical-device-development-services/</loc>
		<lastmod>2010-05-06T12:59:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/11/drug-regulators-ema-emea-publish-concept-paper-on-similar-biologial-products-containing-recombinant-interferon-beta/</loc>
		<lastmod>2010-05-04T07:11:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/10/drug-regulators-ema-emea-publish-draft-concept-paper-on-similar-biological-medicinal-products-containing-recombinant-follicle-stimulating-hormone/</loc>
		<lastmod>2010-05-04T07:06:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/08/drug-regulator-fda-publishes-guidance-on-the-use-of-bayesian-statistics-in-medical-device-clinical-trials/</loc>
		<lastmod>2010-05-04T07:00:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/07/drug-regulators-mhra-extend-deadline-on-nicotine-containing-products-review-to-2nd-june/</loc>
		<lastmod>2010-05-04T06:55:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/06/drug-regulators-fda-cder-publish-guidance-on-ich-q4b-annex-10-polyacrylamide-gel-electrophoresis-general-chapter-for-pharmacopoeial-texts/</loc>
		<lastmod>2010-05-04T06:49:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/05/drug-regulators-fda-cder-publish-guidance-on-ich-q4b-annex-7-dissolution-tests-general-chapter-for-pharmacopoeial-texts/</loc>
		<lastmod>2010-05-04T06:45:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/04/drug-regulators-fda-cder-publish-guidance-on-ich-tablet-friability-q4b-annex-9/</loc>
		<lastmod>2010-05-04T06:40:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/11/twitter-weekly-updates-for-2010-04-11/</loc>
		<lastmod>2010-04-11T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/12/drug-regulators-ema-emea-publishes-a-reflection-paper-on-stem-cell-based-medicinal-products/</loc>
		<lastmod>2010-04-08T09:44:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/11/drug-regulators-ema-emea-publish-a-standard-paediatric-investigation-plan-for-non-adjuvanted-or-adjuvanted-pandemic-influenza-vaccines-during-a-pandemic/</loc>
		<lastmod>2010-04-08T08:43:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/10/drug-regulators-ema-emea-publish-draft-guidance-on-the-evaluation-of-medicinal-products-indicated-for-treatment-of-bacterial-infections/</loc>
		<lastmod>2010-04-08T08:38:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/09/drug-regulators-ema-emea-publish-guideline-on-repeated-dose-toxicity/</loc>
		<lastmod>2010-04-08T08:16:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/08/drug-regulators-ema-emea-publish-overview-of-comments-received-on-guideline-on-repeated-dose-toxicity/</loc>
		<lastmod>2010-04-08T08:07:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/04/twitter-weekly-updates-for-2010-04-04/</loc>
		<lastmod>2010-04-04T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/07/drug-regulators-fda-publish-guidance-on-submission-of-documentation-in-applications-for-parametric-release-of-human-and-veterinary-drug-products-terminally-sterilized-by-moist-heat-processes-2/</loc>
		<lastmod>2010-03-29T10:49:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/06/drug-regulatros-mhra-publish-comment-on-voluntary-parallel-scientific-advice-with-nice-and-the-mhra/</loc>
		<lastmod>2010-03-29T09:26:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/04/drug-regulators-fda-publiash-standards-for-securing-the-drug-supply-chain-standardized-numerical-identification-for-prescription-drug-packages/</loc>
		<lastmod>2010-03-29T09:16:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/03/drug-regulators-fda-publish-guidance-for-industry-dosage-and-administration-section-of-labeling-for-human-prescription-drug-and-biological-products-content-and-format/</loc>
		<lastmod>2010-03-29T09:11:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/02/drug-regulator-fda-publishes-draft-guidance-on-irritable-bowel-syndrome-clinical-evaluation-of-products-for-treatment/</loc>
		<lastmod>2010-03-29T09:06:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/01/drug-regulators-ema-emea-publish-draft-guideline-on-the-clinical-investigation-of-human-normal-immunoglobulin-for-intravenous-administration/</loc>
		<lastmod>2010-03-29T08:59:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/31/drug-regulators-ema-emea-re-publish-note-for-guidance-on-the-investigation-of-bioavailability-and-bioequivalence/</loc>
		<lastmod>2010-03-29T08:55:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/30/drug-regulators-emea-ema-publish-draft-community-list-entry-on-vitis-vinifera-var-tunctoria-l-folium/</loc>
		<lastmod>2010-03-29T08:47:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/29/drug-regulators-ema-emea-publish-comments-received-on-draft-appendix-2-to-the-guideline-on-the-evaluation-of-anticancer-medicinal-products-in-man/</loc>
		<lastmod>2010-03-29T08:43:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/28/twitter-weekly-updates-for-2010-03-28/</loc>
		<lastmod>2010-03-28T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/22/drug-regulator-fda-publishes-guidance-on-pharmacokinetics-in-patients-with-impaired-renal-function-study-design-data-analysis-and-impact-on-dosing-and-labeling/</loc>
		<lastmod>2010-03-22T09:49:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/21/twitter-weekly-updates-for-2010-03-21/</loc>
		<lastmod>2010-03-21T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/16/drug-regulators-emea-ema-publish-draft-guidance-on-the-validation-of-bioanalytical-methods/</loc>
		<lastmod>2010-03-16T10:27:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/15/testimonial/</loc>
		<lastmod>2010-03-15T14:40:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/17/drug-regulators-ema-emea-publish-draft-guidance-on-the-requirements-for-quality-documentation-concerning-biological-investigational-medicinal-products-in-clinical-trials/</loc>
		<lastmod>2010-03-15T13:59:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/16/drug-regulators-fda-publish-guidance-s9-nonclinical-evaluation-for-anticancer-pharmaceuticals/</loc>
		<lastmod>2010-03-15T13:48:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/15/metrc-short-term-project-funding-call/</loc>
		<lastmod>2010-03-15T13:15:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/14/twitter-weekly-updates-for-2010-03-14/</loc>
		<lastmod>2010-03-14T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/14/drug-regulators-fda-publish-guidance-on-the-use-of-bayesian-statistics-in-medical-device-clinical-trails/</loc>
		<lastmod>2010-03-08T08:48:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/13/drug-regulators-mhra-start-public-consultation-to-extend-maximum-treatment-period-and-pack-size-changes-to-voltarol-emugel/</loc>
		<lastmod>2010-03-08T08:43:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/12/drug-regulators-fda-publishes-guidance-on-s9-non-clinical-evaluation-for-anticancer-pharmaceuticals/</loc>
		<lastmod>2010-03-08T08:38:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/12/drug-regulators-ema-emea-publish-concept-paper-on-need-for-revision-of-the-guideline-on-stability-testing-for-applications-for-variations-to-a-marketing-authorisation/</loc>
		<lastmod>2010-03-08T08:31:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/11/drug-regulators-ema-emea-publishes-draft-guidance-on-real-time-release-testing-parametric-release/</loc>
		<lastmod>2010-03-08T08:26:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/11/drug-regulators-eme-emea-publish-concept-paper-on-revision-of-the-guideline-on-process-validation/</loc>
		<lastmod>2010-03-08T08:21:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/10/drug-regulators-ema-emea-publish-consultation-on-its-road-map-to-2015/</loc>
		<lastmod>2010-03-08T08:14:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/09/drug-regulators-fda-publish-guidance-on-characterisation-and-qualification-of-cell-substances-and-other-biological-materials-used-in-the-production-of-viral-vaccines-for-infectious-diseases/</loc>
		<lastmod>2010-03-08T08:07:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/08/drug-regulators-ema-emeapublish-guidance-on-the-development-of-medicinal-products-for-the-treatment-of-alcohol-dependence/</loc>
		<lastmod>2010-03-08T08:01:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/07/twitter-weekly-updates-for-2010-03-07/</loc>
		<lastmod>2010-03-07T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/06/device-regulators-mhra-publish-draft-for-comment-on-vigilance-systems-for-ce-marked-medical-devices-cardiac-ablation-catheters/</loc>
		<lastmod>2010-03-01T11:31:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/04/drug-regulators-fda-publish-draft-guidance-on-adaptive-design-clinical-trials-for-drugs-and-biologicals/</loc>
		<lastmod>2010-03-01T11:25:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/03/drug-regulators-fda-publish-guidance-on-submission-of-documentation-in-applications-for-parametric-release-of-human-and-veterinary-drug-products-terminally-sterilized-by-moist-heat-processes/</loc>
		<lastmod>2010-03-01T10:21:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/02/drug-regulators-fda-publish-draft-guidance-for-industry-non-inferiority-clinical-trials/</loc>
		<lastmod>2010-03-01T10:16:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/01/drug-regulators-mhra-publish-best-practice-guidance-on-the-same-of-pain-relief/</loc>
		<lastmod>2010-03-01T10:09:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/28/twitter-weekly-updates-for-2010-02-28/</loc>
		<lastmod>2010-02-28T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/places-to-visit/</loc>
		<lastmod>2010-02-26T15:41:47+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/01/drug-regulators-emea-ema-publish-comments-draft-guidance-on-the-investigation-of-bioequivalence/</loc>
		<lastmod>2010-02-25T10:54:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/27/drug-regulators-mhra-publish-consultation-document-on-arm-65-algopain-eze-140mg-medicated-plaster-request-to-reclassify-a-prodcut-from-pom-to-p/</loc>
		<lastmod>2010-02-25T10:42:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/26/drug-regulators-ema-emea-publish-draft-guidance-on-clinical-investigations-in-the-treatment-of-diabetes-mellitus/</loc>
		<lastmod>2010-02-25T10:37:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/25/drug-regulators-emea-ema-publish-a-concept-paper-on-the-need-for-guidance-on-clinical-investigations-of-medicinal-products-in-the-treatment-of-diabetes-mellitus/</loc>
		<lastmod>2010-02-25T10:33:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/medqp/</loc>
		<lastmod>2010-02-22T16:17:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/medqp/report-4-atmp-european-regulations-review/</loc>
		<lastmod>2010-02-21T16:21:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/21/twitter-weekly-updates-for-2010-02-21/</loc>
		<lastmod>2010-02-21T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/14/twitter-weekly-updates-for-2010-02-14/</loc>
		<lastmod>2010-02-14T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/17/drug-regulators-fda-publish-guidance-for-industry-on-content-of-a-compleate-submission-for-the-evaluation-of-proprietary-names/</loc>
		<lastmod>2010-02-11T11:10:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/16/drug-regulators-emea-publish-addendum-to-the-note-for-guidance-on-evaluation-of-medicinal-products-indicated-for-the-treatment-of-bacterial-infections/</loc>
		<lastmod>2010-02-11T11:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/15/drug-regulators-emea-publish-an-overview-of-comments-received-on-draft-guidance-on-clinical-investigations-of-medicinal-products-used-in-osteoarthritis/</loc>
		<lastmod>2010-02-11T11:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/14/drug-regulators-emea-publish-concept-paper-on-need-to-revise-points-to-consider-on-the-clinical-investigation-of-medicinal-products-other-than-nsaids-in-rheumatoid-arthritis/</loc>
		<lastmod>2010-02-11T10:57:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/13/drug-regulators-mhra-publish-consultation-letter-mlx-364-the-regulation-of-nicotine-containing-products/</loc>
		<lastmod>2010-02-11T10:53:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/12/drug-regulators-mhra-publish-consultation-intention-to-amend-the-medicines-for-human-use-regulations-2008-si20081692/</loc>
		<lastmod>2010-02-11T10:45:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/11/drug-regulators-emea-publish-overview-of-comments-received-on-selection-of-test-materials-for-genotoxicity-testing-for-traditional-herbal-medicinal-products/</loc>
		<lastmod>2010-02-11T10:40:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/08/report-review-fda-m3r2-nonclinical-safety-pharmaceuticals/</loc>
		<lastmod>2010-02-08T22:33:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/09/drug-regulators-ema-publish-reflection-paper-on-ethanol-content-in-herbal-medicinal-products-and-tranditional-herbal-medicinal-products-used-in-children/</loc>
		<lastmod>2010-02-08T11:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/08/drug-regulators-ema-publish-overview-of-comments-received-on-reflection-paper-ethanol-content-in-herbal-medicinal-products/</loc>
		<lastmod>2010-02-08T11:19:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/07/twitter-weekly-updates-for-2010-02-07/</loc>
		<lastmod>2010-02-07T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/07/drug-regulators-fda-cder-publish-guidance-on-the-assessment-of-abuse-potential-of-drugs/</loc>
		<lastmod>2010-02-01T15:59:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/06/drug-regulators-fda-cder-publish-guidance-on-use-of-mechanical-calibration-of-dissolution-apparatus-cgmp/</loc>
		<lastmod>2010-02-01T15:55:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/05/drug-regulators-emea-release-overview-of-comments-received-on-draft-guidance-on-clinical-evaluation-of-diagnostic-agents/</loc>
		<lastmod>2010-02-01T15:51:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/04/drug-regulators-emea-publish-guideline-on-investigations-of-medicinal-products-in-the-treatment-of-epileptic-disorders/</loc>
		<lastmod>2010-02-01T15:48:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/03/drug-regulators-emea-publish-guidance-on-clinical-investigations-of-medicinal-products-intended-for-the-treatment-of-glucocorticoid-induced-osteoporosis/</loc>
		<lastmod>2010-02-01T15:44:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/02/drug-regulators-emea-publish-guidlines-on-the-investigation-of-bioequivalence/</loc>
		<lastmod>2010-02-01T15:39:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/01/drug-regulators-emea-publish-draft-concept-paper-on-the-risk-based-approach-for-advanced-therapy-medical-products/</loc>
		<lastmod>2010-02-01T15:36:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/01/dedication-recognised-ida-wins-award-for-mentor-work/</loc>
		<lastmod>2010-02-01T11:44:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/31/twitter-weekly-updates-for-2010-01-31/</loc>
		<lastmod>2010-01-31T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/25/drug-regulators-emea-publish-guidance-on-herbal-medicinal-products-test-materials-for-genotoxicity/</loc>
		<lastmod>2010-01-25T09:17:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/24/twitter-weekly-updates-for-2010-01-24/</loc>
		<lastmod>2010-01-24T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/24/drug-regulators-fda-cder-publish-guidance-to-pharmacies-on-compounding-oral-suspension/</loc>
		<lastmod>2010-01-18T09:08:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/23/drug-regulators-fda-publishes-guidance-for-irbs-clinical-investigators-and-sponsors/</loc>
		<lastmod>2010-01-18T09:04:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/22/70-million-boost-for-uk-manufacturing-including-regenerative-medicines/</loc>
		<lastmod>2010-01-18T09:01:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/21/device-regulators-mhra-publish-poster-on-mattress-decontamination/</loc>
		<lastmod>2010-01-18T08:56:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/20/drug-regulators-emea-publish-guidance-on-the-evaluation-of-drugs-for-the-treatment-of-gastroesophageal-reflux-disease/</loc>
		<lastmod>2010-01-18T08:53:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/19/drug-regulators-european-medicines-agency-publish-concept-paper-on-revision-of-the-notes-for-guidance-on-gene-transfer-medicinal-products/</loc>
		<lastmod>2010-01-18T08:49:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/18/drug-regulators-emea-publish-questions-and-answers-on-gene-therapy/</loc>
		<lastmod>2010-01-18T08:42:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/18/jamaican-blue-mountain-coffee/</loc>
		<lastmod>2010-01-18T08:37:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/17/twitter-weekly-updates-for-2010-01-17/</loc>
		<lastmod>2010-01-17T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/12/drug-regulatory-guidance-planning-for-the-effects-of-high-absenteeism-to-ensure-availability-of-medically-necessary-drug-products/</loc>
		<lastmod>2010-01-11T08:15:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/11/drug-regulators-fda-publish-guidance-for-industry-on-new-contrast-imaging-indication-considerations-for-devices-and-approved-drug-and-biological-products/</loc>
		<lastmod>2010-01-11T08:07:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/10/twitter-weekly-updates-for-2010-01-10/</loc>
		<lastmod>2010-01-10T12:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/10/twitter-weekly-updates-for-2010-01-10-2/</loc>
		<lastmod>2010-01-10T12:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/how-to-write-a-business-plan/</loc>
		<lastmod>2010-01-05T10:10:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/09/drug-regulators-fda-publish-guidance-on-an-acceptable-circular-of-information-for-the-use-of-human-blood-and-blood-components/</loc>
		<lastmod>2010-01-05T09:47:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/08/drug-regulators-fda-cder-publish-guidance-on-q4b-annex-8-sterility-test-general-chapter-for-ich-regions/</loc>
		<lastmod>2010-01-05T07:39:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/07/drug-regulators-fda-cder-publish-guidance-on-q4b-annex5-disintegration-test-general-chapter-for-ich-regions/</loc>
		<lastmod>2010-01-05T07:35:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/06/drug-regulator-mhra-publishes-an-updated-guide-for-manufactures-on-clinical-investigations-to-be-carried-out-in-the-uk/</loc>
		<lastmod>2010-01-05T07:31:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/05/drug-regulator-mhra-starts-consultation-on-measures-to-strengthen-the-medicines-supply-chain-and-reduce-the-risk-of-counterfit-medicines/</loc>
		<lastmod>2010-01-05T07:26:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/27/twitter-weekly-updates-for-2009-12-27/</loc>
		<lastmod>2009-12-27T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/26/drug-regulators-emea-publish-ich-m2-common-technical-document-updated-qa/</loc>
		<lastmod>2009-12-24T10:07:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/25/drug-regulators-publish-ich-m2-business-requirements-guidance/</loc>
		<lastmod>2009-12-24T10:03:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/24/drug-regulators-publish-ich-q4b-annex-7-dissolution-test-general-chapter-guidance/</loc>
		<lastmod>2009-12-24T10:00:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/31/drug-regulators-emea-publish-ich-q4b-annex-10-polyacrylamide-gel-electrophoresis-general-chapter-guidance/</loc>
		<lastmod>2009-12-24T09:57:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/30/drug-regulators-emea-publish-ich-q4b-annex-12-analytical-sieving-general-chapter-guidance/</loc>
		<lastmod>2009-12-24T09:53:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/29/drug-regulators-emea-publishes-ich-q4b-annex-11-capillary-electrophoresis-general-chapter-guidance/</loc>
		<lastmod>2009-12-24T09:50:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/28/drug-regulators-emea-publish-ichq8q9-q10-note-for-guidance-on-pharmaceutical-development-quality-risk-management-and-quality-systems-qa/</loc>
		<lastmod>2009-12-24T09:46:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/27/drug-regulators-emea-publish-ich-s6r1-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/</loc>
		<lastmod>2009-12-24T09:33:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/26/drug-regulators-emea-publish-ich-s9-guidance-nonclinical-evaluation-for-anticancer-pharmaceuticals/</loc>
		<lastmod>2009-12-24T09:28:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/25/drug-regulators-fda-publish-addendum-to-ich-s6-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals-s6r1/</loc>
		<lastmod>2009-12-23T09:50:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/24/drug-regulators-fda-publish-q4b-evaluation-and-recommendations-for-pharmacopeial-texts-for-use-in-ich-regions-annex-12-analytical-sieving-general-chapter/</loc>
		<lastmod>2009-12-23T09:45:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/23/drug-regulators-fda-publish-q4b-evaluation-and-recomendations-for-pharmacopeial-texts-for-use-in-ich-regions-annex-11-capillary-electrophoresis-general-chapter/</loc>
		<lastmod>2009-12-23T09:40:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/31/drug-regulators-emea-publish-draft-guidance-on-validation-of-bioanalytical-methods/</loc>
		<lastmod>2009-12-23T09:35:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/30/drug-regulators-fda-cder-publish-guidance-on-pet-drugs-current-good-manufacturing-practice-cgmp/</loc>
		<lastmod>2009-12-23T09:31:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/29/drug-regulators-fda-cder-publish-guidance-on-patient-reported-outcome-measures-use-in-medical-product-development-to-support-labeling-claims/</loc>
		<lastmod>2009-12-23T09:28:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/28/drug-regulators-mhra-publish-guidance-on-the-vigilance-system-for-ce-marked-medical-devices/</loc>
		<lastmod>2009-12-23T09:23:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/27/uk-regulator-mhra-publishes-ecg-top-tips-poster/</loc>
		<lastmod>2009-12-23T09:20:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/27/drug-regulators-emea-publish-guidance-on-clinical-investigations-for-pulmonary-arterial-hypertension/</loc>
		<lastmod>2009-12-23T09:14:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/26/drug-regulators-emea-publish-concept-paper-on-the-need-for-clinical-guidelines-for-the-investigation-of-medicinal-products-for-the-treatment-of-systemic-and-cutaneous-lupus-erythematosus/</loc>
		<lastmod>2009-12-23T08:55:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/25/drug-regulators-fda-cder-publish-draft-guidance-on-assay-development-for-immunogenicity-testing-of-therapeutic-proteins/</loc>
		<lastmod>2009-12-23T08:48:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/24/drug-regulator-emea-publishes-new-visual-identity-webemail-addresses-and-organisation-chart-for-the-european-medicines-agency/</loc>
		<lastmod>2009-12-23T08:34:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/23/good-publication-practice-for-communicating-company-sponsored-medical-research-the-gpp2-guidelines-published/</loc>
		<lastmod>2009-12-22T08:08:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/22/department-of-health-announce-an-innovation-pass-pilot/</loc>
		<lastmod>2009-12-22T08:04:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/31/drug-regulators-emea-publish-guidline-on-xenogenic-cell-based-medicinal-products/</loc>
		<lastmod>2009-12-22T08:00:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/30/drug-regulators-emea-publish-guidance-of-the-development-of-medicinal-products-for-the-treatment-of-cystic-fibrosis/</loc>
		<lastmod>2009-12-22T07:56:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/29/drug-regulators-fda-publish-guidance-for-industry-on-residual-solvents-in-drug-products-marketed-in-the-usa/</loc>
		<lastmod>2009-12-22T07:47:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/28/drug-regulators-emea-summarise-comments-received-on-draft-guidance-on-similar-biologicals-containing-low-molecular-weight-heparins/</loc>
		<lastmod>2009-12-22T07:43:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/27/drug-regulators-emea-publish-concept-paper-on-the-development-of-a-guidance-on-similar-biological-medicinal-products-containing-monoclonal-antibodies/</loc>
		<lastmod>2009-12-22T07:40:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/26/drug-regulators-fda-publish-questions-and-answers-on-gmp-and-production-process-control/</loc>
		<lastmod>2009-12-22T07:34:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/25/drug-regulators-fda-publishes-guidance-on-pharmaceutical-development-q8r2/</loc>
		<lastmod>2009-12-22T07:30:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/24/drug-regulators-fda-publish-draft-guidance-on-manufactures-of-human-cellstissues-and-cellular-and-tissue-based-products/</loc>
		<lastmod>2009-12-22T07:26:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/23/drug-regulators-emea-publish-reflection-paper-on-the-extrapolation-of-results-from-clinical-studies-conducted-outside-the-eu/</loc>
		<lastmod>2009-12-22T07:19:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/22/drug-regulators-fda-publish-guidance-on-the-use-of-nucleic-acid-tests-to-reduce-the-risk-of-transmission-of-west-nile-virus-from-blood-donors/</loc>
		<lastmod>2009-12-22T07:14:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/16/drug-regulators-fda-publish-draft-guidance-on-the-assessment-of-blood-donor-suitability-product-safety-and-preservation-of-the-blood-supply-in-response-to-h1n1-pandemic/</loc>
		<lastmod>2009-12-16T10:29:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/16/drug-regulators-emea-chmp-publish-guidance-on-follow-up-patients-adminstered-with-gene-therapy-medical-products/</loc>
		<lastmod>2009-12-16T10:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/16/fda-publishes-draft-guidance-on-e7-studies-in-support-of-special-populations-geriatrics-qa/</loc>
		<lastmod>2009-12-16T10:19:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/13/twitter-weekly-updates-for-2009-12-13/</loc>
		<lastmod>2009-12-13T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/11/medical-device-classification-not-centrally-stored/</loc>
		<lastmod>2009-12-11T09:15:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/10/new-10-tax-rate-for-patent-income/</loc>
		<lastmod>2009-12-10T09:28:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/09/new-fund-available-for-industry-uni-tie-ups/</loc>
		<lastmod>2009-12-09T11:35:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/drug-development-and-planning-services/liver-toxicity-fda-dili-expert-reporting/</loc>
		<lastmod>2009-12-08T19:00:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/13/emea-publishes-comments-received-on-development-of-guidance-for-products-for-treating-smoking/</loc>
		<lastmod>2009-12-08T08:15:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/12/fda-convenes-meeting-regarding-online-advertising/</loc>
		<lastmod>2009-12-08T08:04:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/11/emea-publishes-draft-guidance-on-the-development-of-medical-products-for-insomnia/</loc>
		<lastmod>2009-12-08T07:54:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/10/emea-sme-scheme-reminder/</loc>
		<lastmod>2009-12-08T07:49:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/09/mhra-re-publish-guidance-on-how-they-regulate-traditional-herbal-medicines-thmrs/</loc>
		<lastmod>2009-12-08T07:23:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/08/mhra-puts-new-traditional-herbal-medicines-registration-scheme-page-live/</loc>
		<lastmod>2009-12-08T07:19:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/06/twitter-weekly-updates-for-2009-12-06/</loc>
		<lastmod>2009-12-06T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/06/european-directive-on-transitional-qualified-persons-for-herbal-medicines/</loc>
		<lastmod>2009-11-30T10:30:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/05/drug-regulators-fda-publish-guidance-on-nucleic-acid-tests-to-reduce-risk-of-west-nile-virus-from-whole-blood-donors/</loc>
		<lastmod>2009-11-30T10:26:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/04/drug-regulators-fda-publish-guidance-on-dosage-delivery-devices-for-otc-liquid-drug-products/</loc>
		<lastmod>2009-11-30T10:20:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/03/ich-press-release/</loc>
		<lastmod>2009-11-30T10:11:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/02/drug-regulators-emea-publish-concept-paper-on-revision-of-guidelines-on-radiopharmaceuticals-based-on-monoclonal-antibodies/</loc>
		<lastmod>2009-11-30T10:04:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/01/european-commission-2006-guidance-reminder-conditional-approval/</loc>
		<lastmod>2009-11-30T09:58:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/30/drug-regulators-emea-publish-guidance-on-the-development-of-therapies-for-cystic-fibrosis/</loc>
		<lastmod>2009-11-30T09:54:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/29/twitter-weekly-updates-for-2009-11-29/</loc>
		<lastmod>2009-11-29T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/24/drug-regulators-fda-cder-publish-updated-guidance-on-investigator-responsibilities-for-study-subjects/</loc>
		<lastmod>2009-11-24T16:19:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/22/twitter-weekly-updates-for-2009-11-22/</loc>
		<lastmod>2009-11-22T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/20/liver-toxicity-fda-dili-regulations-require-interpretation/</loc>
		<lastmod>2009-11-20T16:15:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/23/drug-regulators-fda-cder-publishes-guidance-on-spl-standard-for-content-of-labeling-technical-qs-as/</loc>
		<lastmod>2009-11-20T14:34:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/19/how-much-does-the-tax-man-owe-you/</loc>
		<lastmod>2009-11-19T16:54:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/22/european-commission-publishes-assessment-of-the-functioning-of-the-clinical-trials-directive/</loc>
		<lastmod>2009-11-18T11:42:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/21/drug-regulator-emea-publishes-ich-guidance-on-the-use-of-oncolytic-viruses/</loc>
		<lastmod>2009-11-18T11:35:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/20/drug-regulators-emea-re-publish-guidance-on-special-populations-geriatrics/</loc>
		<lastmod>2009-11-18T11:25:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/19/medical-device-regulators-publish-guidance-on-vigilance-systems-breast-implants/</loc>
		<lastmod>2009-11-18T11:13:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/18/ida-adds-herbal-medicines-expertise-to-offerings/</loc>
		<lastmod>2009-11-18T10:13:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/15/twitter-weekly-updates-for-2009-11-15/</loc>
		<lastmod>2009-11-15T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/12/the-ethics-of-phase-1-research-in-patients/</loc>
		<lastmod>2009-11-12T16:11:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/16/drug-regulators-fda-publish-guidance-for-minimally-manipulated-unrelated-allogenic-placentalumbilical-cord-blood-intended-for-hematopoiteic-reconstitution-for-specific-indications/</loc>
		<lastmod>2009-11-10T15:19:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/14/drug-regulators-fda-publish-draft-guidance-on-inds-for-minimally-manipulated-unrelated-allogenic-placentalumbilical-cord-blood/</loc>
		<lastmod>2009-11-10T15:11:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/13/fda-publishes-guidance-on-circular-information-for-the-use-of-human-blood-and-blood-components/</loc>
		<lastmod>2009-11-10T15:06:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/12/drug-regulators-fda-publish-a-good-review-practice-guidance-for-labeling-for-human-prescription-drug-and-biological-products/</loc>
		<lastmod>2009-11-10T15:02:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/11/drug-regulators-publish-concept-paper-on-the-need-to-revise-clinical-guidance-for-depression/</loc>
		<lastmod>2009-11-10T14:57:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/10/drug-regulators-emea-publish-draft-guidance-on-the-use-of-near-infrared-spectroscopy/</loc>
		<lastmod>2009-11-10T14:44:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/08/twitter-weekly-updates-for-2009-11-08/</loc>
		<lastmod>2009-11-08T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/06/eu-directive-updated-advanced-therapy-medical-products/</loc>
		<lastmod>2009-11-02T20:25:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/05/drug-regulators-publish-draft-guidance-on-helicobacter-pylori-associated-duodenal-ulcer-treatments/</loc>
		<lastmod>2009-11-02T20:17:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/04/regulators-publish-draft-guidance-for-industry-on-risk-evaluation-and-mitigation-strategies-rems/</loc>
		<lastmod>2009-11-02T16:52:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/03/drug-regulatos-publish-draft-reflection-paper-on-in-vitro-cultured-chondrocyte-containing-products-for-cartilage-repair/</loc>
		<lastmod>2009-11-02T16:46:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/02/deviceregulators-publish-guidance-notice-on-borderlines-with-medical-devices/</loc>
		<lastmod>2009-11-02T16:40:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/02/coffee-lovers-look-out/</loc>
		<lastmod>2009-11-02T11:36:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/01/twitter-weekly-updates-for-2009-11-01/</loc>
		<lastmod>2009-11-01T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/01/merck-co-great-strategy-for-tropical-disease-voucher-production/</loc>
		<lastmod>2009-10-26T11:24:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/31/fda-publishes-new-guidance-page-memoranda-to-blood-establishments/</loc>
		<lastmod>2009-10-26T11:14:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/30/drug-regulators-publish-guidance-for-allogenic-pancreatic-islet-cell-products/</loc>
		<lastmod>2009-10-26T11:10:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/29/drug-regulators-publish-draft-guidance-on-development-analysis-and-presentaion-of-microbological-data-for-systemic-antibarterial-drugs/</loc>
		<lastmod>2009-10-26T10:13:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/28/drug-regulators-publish-guidance-on-end-of-phase-2a-meetings/</loc>
		<lastmod>2009-10-26T10:08:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/27/drug-regulators-publish-draft-guidance-on-biosimilars-for-recombinant-erthropoietins/</loc>
		<lastmod>2009-10-26T10:04:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/26/drug-regulators-publish-draft-clinical-guidelines-for-cancer-vaccines/</loc>
		<lastmod>2009-10-26T09:59:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/25/twitter-weekly-updates-for-2009-10-25/</loc>
		<lastmod>2009-10-25T13:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/18/twitter-weekly-updates-for-2009-10-18/</loc>
		<lastmod>2009-10-18T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/16/european-medicines-agency-implements-internal-reorganisation/</loc>
		<lastmod>2009-10-16T15:21:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/16/the-human-fertilisation-and-embryology-act-comes-into-force/</loc>
		<lastmod>2009-10-16T15:17:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/16/pan-african-registry-is-given-who-thumbs-up/</loc>
		<lastmod>2009-10-16T15:14:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/16/metrc-announce-short-term-project-funding/</loc>
		<lastmod>2009-10-16T14:59:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/22/drug-regulator-publishes-core-spc-for-pandemic-influenza-vaccines/</loc>
		<lastmod>2009-10-16T14:22:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/21/drug-regulators-publish-qa-on-ich-m2-common-technical-document-for-the-registration-of-pharmaceuticals-for-human-use/</loc>
		<lastmod>2009-10-16T14:19:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/20/drug-regulators-publish-draft-guidance-on-development-of-similar-recombinant-erythroproetins-containing-prodcuts/</loc>
		<lastmod>2009-10-16T14:13:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/19/parallel-scientific-advice-at-the-regualtors/</loc>
		<lastmod>2009-10-16T14:06:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/18/drug-regulators-publish-guidance-on-tacrolimus-development/</loc>
		<lastmod>2009-10-16T14:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/17/drug-regualtors-publish-intnetion-to-change-regualtiosn-on-sale-supply-and-administration-of-drus-and-dental-hygenists-and-dental-therapists/</loc>
		<lastmod>2009-10-16T13:55:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/16/drug-regulators-publish-guidnace-for-formal-meetings/</loc>
		<lastmod>2009-10-16T13:50:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/12/drug-regulators-publish-guidance-on-use-of-accredited-persons-under-the-accredited-persons-inspection-programme/</loc>
		<lastmod>2009-10-12T13:11:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/12/drug-regulators-publish-labeling-qas-for-non-prescription-human-drugs/</loc>
		<lastmod>2009-10-12T13:06:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/12/drug-regulators-publishes-guidance-on-managing-donor-risk-for-hiv-1/</loc>
		<lastmod>2009-10-12T13:01:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/12/drug-regulators-publish-draft-guidnace-on-consumer-advertising-of-traditional-herbal-medicines/</loc>
		<lastmod>2009-10-12T12:56:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/12/device-regulators-publish-guidance-on-vigilance-system-for-ce-marked-breast-implants/</loc>
		<lastmod>2009-10-12T12:52:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/11/twitter-weekly-updates-for-2009-10-11/</loc>
		<lastmod>2009-10-11T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/how-to-write-a-business-plan/yef-how-to-write-a-business-plan/</loc>
		<lastmod>2009-10-06T14:49:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/04/twitter-weekly-updates-for-2009-10-04/</loc>
		<lastmod>2009-10-04T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/30/biological-regulators-provide-guidance-on-submission-of-lot-release-protocols/</loc>
		<lastmod>2009-09-30T09:27:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/30/drug-regulators-publish-q4b-annex9-tablet-friability-general-chapter/</loc>
		<lastmod>2009-09-30T09:23:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/30/drug-regulators-publish-concept-paper-on-cjd-in-plasma-derived-and-urine-derived-medical-products/</loc>
		<lastmod>2009-09-30T09:11:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/30/us-senate-votes-to-improve-drug-trial-access/</loc>
		<lastmod>2009-09-30T08:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/29/drug-regulators-publish-concept-paper-on-clinical-investigation-of-specific-immunoglobulins/</loc>
		<lastmod>2009-09-29T14:01:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/29/drug-regulators-publish-guidance-on-clinical-evaluation-of-diagnostic-agents/</loc>
		<lastmod>2009-09-29T13:57:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/29/drug-regulators-publish-draft-guidance-on-clinical-investigations-for-factor-ix-products/</loc>
		<lastmod>2009-09-29T13:50:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/29/drug-regulators-publish-draft-guidance-on-clinical-investigations-for-factor-viii-products/</loc>
		<lastmod>2009-09-29T13:47:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/29/regulators-publish-qas-on-ewp-therapeutic-subgroups-on-pharmacokinetics/</loc>
		<lastmod>2009-09-29T13:43:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/28/drug-regulators-publish-concept-paper-requiremtns-for-guidance-on-the-clinical-investigation-of-products-for-lipid-disorders-and-hypertension/</loc>
		<lastmod>2009-09-28T08:25:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/28/drug-regulators-publish-concept-paper-on-paediatirc-pulmonary-arterial-hypertension/</loc>
		<lastmod>2009-09-28T08:20:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/28/drug-regulators-publish-guidance-on-the-investigation-of-medicincal-products-in-the-term-and-preterm-neonate/</loc>
		<lastmod>2009-09-28T08:14:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/28/drug-regulators-publish-draft-guidance-on-e16-genomic-biomarkers-related-to-drug-response/</loc>
		<lastmod>2009-09-28T08:09:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/28/drug-regulators-publish-guidance-on-risk-for-melamine-contamination/</loc>
		<lastmod>2009-09-28T08:04:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/20/twitter-weekly-updates-for-2009-09-20-2/</loc>
		<lastmod>2009-09-20T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/14/drug-regulatos-fda-reppost-guidance-on-cmc-submissions-for-therapeutic-recombinant-dna-derived-products-or-monolconal-antibody-products/</loc>
		<lastmod>2009-09-14T08:08:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/13/twitter-weekly-updates-for-2009-09-13/</loc>
		<lastmod>2009-09-13T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/08/drug-regulators-publish-concept-paper-on-cjd-and-plasma-derived-medicinal-products/</loc>
		<lastmod>2009-09-08T09:22:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/07/uk-drug-regulators-release-new-information-on-medical-devices-directive/</loc>
		<lastmod>2009-09-07T06:48:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/06/twitter-weekly-updates-for-2009-09-06/</loc>
		<lastmod>2009-09-06T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/30/twitter-weekly-updates-for-2009-08-30/</loc>
		<lastmod>2009-08-30T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/27/drug-regulators-international-collaberation-on-gcp-inspections/</loc>
		<lastmod>2009-08-27T09:45:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/26/drug-regulators-publish-guidance-on-nat-testing-to-reduce-the-risk-of-contamination-of-plasma-derived-products/</loc>
		<lastmod>2009-08-26T09:35:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/25/drug-regulators-publish-concept-paper-on-clinical-investigations-of-specific-immunoglobulins/</loc>
		<lastmod>2009-08-25T10:17:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/24/draft-guidance-published-by-drug-regulators-on-ce-marked-medical-devices-neurostimulators/</loc>
		<lastmod>2009-08-24T07:02:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/23/twitter-weekly-updates-for-2009-08-23/</loc>
		<lastmod>2009-08-23T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/21/drug-regulators-publish-ich-consideration-on-virus-and-vector-shredding/</loc>
		<lastmod>2009-08-21T07:02:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/19/drug-development-guidance-fda-publish-drug-induced-livery-injust-evaluation-guidance/</loc>
		<lastmod>2009-08-19T13:05:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/18/drug-regulators-emea-publish-concept-paper-on-the-need-to-revise-the-guidlines-on-the-use-of-transgenic-animals-in-biological-manufacture/</loc>
		<lastmod>2009-08-18T09:58:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/10/regulatory-round-up/</loc>
		<lastmod>2009-08-17T14:09:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/17/drug-development-guidance-emea-for-medical-products-for-term-and-preterm-neonates/</loc>
		<lastmod>2009-08-17T14:06:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/16/twitter-weekly-updates-for-2009-08-16/</loc>
		<lastmod>2009-08-16T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/14/biotech-development-guidance-draft-serological-test-guidance-from-fda/</loc>
		<lastmod>2009-08-14T08:43:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/13/drug-development-guidance-fda-guidance-on-postmarketing-adverse-event-reporting/</loc>
		<lastmod>2009-08-13T08:34:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/12/drug-development-guidance-fda-publish-impurities-guidance-for-andas/</loc>
		<lastmod>2009-08-12T09:34:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/11/post-markeing-clinical-trials-planning-imprelentation-of-the-fda-section-505o-draft-guidance/</loc>
		<lastmod>2009-08-11T08:14:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/10/increase-your-project-success-guest-report/</loc>
		<lastmod>2009-08-10T13:25:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/10/clinical-trial-regulations-fda-publishes-faq-on-irb-registration/</loc>
		<lastmod>2009-08-10T07:33:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/09/twitter-weekly-updates-for-2009-08-09/</loc>
		<lastmod>2009-08-09T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/07/genomic-medicine-house-of-lords-science-and-technology-committee-publishes-report/</loc>
		<lastmod>2009-08-07T07:57:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/06/clinical-trials-regulations-eu-commission-clinical-trials-draft-regulations/</loc>
		<lastmod>2009-08-06T11:11:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/05/drug-regulations-mhra-draft-guidance-on-atmp-under-the-hospital-exemption-scheme/</loc>
		<lastmod>2009-08-05T08:13:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/04/ytko-testamonial/</loc>
		<lastmod>2009-08-04T09:53:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/04/drug-regulators-fda-new-draft-guidance/</loc>
		<lastmod>2009-08-04T08:21:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/03/increased-biotech-market-protection-usa/</loc>
		<lastmod>2009-08-03T07:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/02/twitter-weekly-updates-for-2009-08-02/</loc>
		<lastmod>2009-08-02T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/31/drug-regulators-traditional-herbal-medicines-advertising-guidance/</loc>
		<lastmod>2009-07-31T07:13:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/30/drug-regulations-emea-publishes-ich-e16-genomic-biomarkers-for-drug-responses/</loc>
		<lastmod>2009-07-31T07:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/archives/</loc>
		<lastmod>2009-07-28T17:38:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/27/drug-development-regulations-emea-releases-draft-guidline-on-epidemiology-data-on-blood-transmissible-infections/</loc>
		<lastmod>2009-07-27T06:36:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/26/twitter-weekly-updates-for-2009-07-26/</loc>
		<lastmod>2009-07-26T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/24/drugbiotech-development-fund-uk-government-announces-gb150m-fund/</loc>
		<lastmod>2009-07-24T07:37:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/23/fda-introduces-new-rules-of-irb-registration/</loc>
		<lastmod>2009-07-23T08:36:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/21/drug-markets-usa-regulators-go-after-deals-that-slow-generic-competition/</loc>
		<lastmod>2009-07-21T08:27:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/20/nice-blueprint-for-fast-track-drugs-in-nice-bypass/</loc>
		<lastmod>2009-07-20T07:28:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/20/development-funding-new-15million-venture-capital-fund-in-north-west/</loc>
		<lastmod>2009-07-20T06:52:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/19/twitter-weekly-updates-for-2009-07-19/</loc>
		<lastmod>2009-07-19T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/18/drug-regulators-emea-publishes-qa-on-ich-m2-ectd/</loc>
		<lastmod>2009-07-17T14:02:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/17/drug-regulators-publish-reflection-paper-development-of-similar-interferon-alfa/</loc>
		<lastmod>2009-07-17T08:28:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/16/drug-development-regulations-q4b-annex/</loc>
		<lastmod>2009-07-16T08:38:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/15/drug-regulations-fda-labeling-for-susceptibility-test-in-systemic-antibacterial-drug-products/</loc>
		<lastmod>2009-07-15T14:40:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/14/herbal-drug-regulations-emea-draft-guidance-on-genotoxicity-testing-for-traditional-herbal-medicinal-products/</loc>
		<lastmod>2009-07-13T18:30:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/12/european-commission-report-signals-increased-scrutiny-of-competition-in-pharmaceutical-sector/</loc>
		<lastmod>2009-07-12T21:09:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/12/quotient-clinical-announces-the-award-of-supplementary-accreditation-by-the-mhra/</loc>
		<lastmod>2009-07-12T20:55:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/12/twitter-weekly-updates-for-2009-07-12/</loc>
		<lastmod>2009-07-12T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/10/drug-biotech-regulations-emea-transparency-policy-draft-for-public-consultation/</loc>
		<lastmod>2009-07-10T07:09:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/06/the-impact-of-the-clinical-trails-directive/</loc>
		<lastmod>2009-07-06T08:02:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/05/twitter-weekly-updates-for-2009-07-05/</loc>
		<lastmod>2009-07-05T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/03/drug-development-logic-models-of-pathway-biology/</loc>
		<lastmod>2009-07-03T07:33:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/02/drug-development-regulations-and-guidance-from-emea-clinical-evaluation-of-antifugals/</loc>
		<lastmod>2009-07-02T09:45:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/01/pharmaceutical-development-annex-guidance-from-fda/</loc>
		<lastmod>2009-07-01T11:25:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/15/emea-puts-out-a-new-concept-paper-developing-a-guidline-for-the-use-of-pharmcogenomic-methodologies-in-the-pharmacokinetic-evaluation-of-medicinal-products/</loc>
		<lastmod>2009-07-01T10:36:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/18/fda-guidance-submission-of-bioequivalence-data-for-andas/</loc>
		<lastmod>2009-07-01T10:35:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/19/a-thought-provoking-consideration-of-surrogate-endpoints/</loc>
		<lastmod>2009-07-01T10:34:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/20/eu-announces-246-million-euros-of-medical-research-funding-and-tells-us-what-they-are-looking-for-in-the-next-round/</loc>
		<lastmod>2009-07-01T10:34:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/27/emea-re-post-draft-guidance-on-the-clinical-evaluation-of-anti-virals-intended-for-hepc/</loc>
		<lastmod>2009-07-01T10:32:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/28/emea-republish-points-to-consider-on-clinical-investigation-of-medicinal-products-used-in-the-treatment-of-osteoarthritis/</loc>
		<lastmod>2009-07-01T10:31:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/29/emea-re-posts-points-to-consider-on-missing-data/</loc>
		<lastmod>2009-07-01T10:30:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/01/emea-guidlines-on-clinical-investigation-of-medicinal-products-for-the-treatment-of-ankylosing-spondylitis/</loc>
		<lastmod>2009-07-01T10:29:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/01/mhra-publishes-guidance-on-the-medical-devices-directives/</loc>
		<lastmod>2009-07-01T10:29:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/02/emea-issue-draft-guidance-on-plasma-derived-medicinal-products/</loc>
		<lastmod>2009-07-01T10:25:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/04/emea-publishes-concept-paper-on-the-development-of-guidlines-on-the-use-of-pharmacogenomic-methodogologies-in-pk-evaluation/</loc>
		<lastmod>2009-07-01T10:23:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/05/new-manchester-university-spin-out-fund/</loc>
		<lastmod>2009-07-01T10:23:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/08/ida-consultants-provides-regulatory-roadmap/</loc>
		<lastmod>2009-07-01T10:22:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/01/client-testamonial/</loc>
		<lastmod>2009-07-01T09:19:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/about/</loc>
		<lastmod>2009-07-01T09:11:02+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/29/apple-puts-onus-of-fda-clearance-on-iphone-developers/</loc>
		<lastmod>2009-06-29T11:41:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/28/twitter-weekly-updates-for-2009-06-28/</loc>
		<lastmod>2009-06-28T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/26/drug-patent-settlements-cost-consumers-us3-5bn-annualy-in-the-usa/</loc>
		<lastmod>2009-06-26T09:00:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/25/non-gmp-stock-allowable-for-human-radiolabled-pk-studies/</loc>
		<lastmod>2009-06-25T08:26:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/24/drugmakers-reach-deal-to-reduce-us-medicare-coverage-gap/</loc>
		<lastmod>2009-06-24T15:10:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/22/mhra-guidance-on-the-vigilance-systems-the-steam-out-of-medical-devices-intraocular-lenses/</loc>
		<lastmod>2009-06-22T08:32:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/21/twitter-weekly-updates-for-2009-06-21/</loc>
		<lastmod>2009-06-21T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/19/guidline-on-quality-non-clinical-and-clinical-aspects-of-live-recombinant-viral-vectored-vaccines/</loc>
		<lastmod>2009-06-19T08:21:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/18/guest-article-the-fight-against-influenza/</loc>
		<lastmod>2009-06-18T13:05:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/15/customer-testemonial/</loc>
		<lastmod>2009-06-15T07:34:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/14/twitter-weekly-updates-for-2009-06-14/</loc>
		<lastmod>2009-06-14T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/12/fda-guidance-q8r1-pharamceutical-development-submission-contents-and-overall-pharmaceutical-development-guidance/</loc>
		<lastmod>2009-06-12T15:13:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/11/technology-strategy-board-new-competitions/</loc>
		<lastmod>2009-06-11T07:16:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/10/correction-on-n8/</loc>
		<lastmod>2009-06-10T18:54:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/10/n8-metrc-and-an-associated-proof-of-concept-fund/</loc>
		<lastmod>2009-06-10T18:48:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/07/twitter-weekly-updates-for-2009-06-07/</loc>
		<lastmod>2009-06-07T14:20:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/14/functional-foods-overstep-the-claims-are-cheerios-a-drug-the-fda-think-so/</loc>
		<lastmod>2009-05-14T08:16:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/13/us-governemet-to-spend-us11-billion-on-evidence-based-medicine/</loc>
		<lastmod>2009-05-13T13:12:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/11/pause-in-normal-service/</loc>
		<lastmod>2009-05-11T15:04:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/10/fda-approves-first-ever-human-drug-from-geneticaly-engineered-animals/</loc>
		<lastmod>2009-05-10T19:32:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/04/fda-guidance-for-industry-intergrated-summaries-of-effectivenss-and-safety-location-within-the-common-technical-document/</loc>
		<lastmod>2009-05-05T05:51:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/03/fda-draft-guidance-label-comprehension-studies-for-non-prescription-drug-products/</loc>
		<lastmod>2009-05-04T19:19:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/03/the-pharmaceutical-industry-faces-unprecedented-barriers-to-evolution/</loc>
		<lastmod>2009-05-03T15:23:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/03/emea-publishes-a-reflection-paper-recombinant-adeno-associated-viral-vectors/</loc>
		<lastmod>2009-05-03T14:36:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/03/new-emea-draft-concept-paper-immunogenicity-assessment-of-manoclonal-antibodies-for-in-vivo-clinical-use/</loc>
		<lastmod>2009-05-03T14:07:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/29/over-220-million-to-boost-innovation-in-the-nhs/</loc>
		<lastmod>2009-04-29T08:07:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/28/new-draft-fda-guidance-on-somatic-cell-therapy-for-cardiac-disease/</loc>
		<lastmod>2009-04-28T08:07:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/28/188/</loc>
		<lastmod>2009-04-28T08:05:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/02/new-fda-draft-guidance-non-clinical-evaluation-for-anticancer-pharmaceuticals/</loc>
		<lastmod>2009-04-28T07:35:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/27/phrma-issues-revised-principles-on-conduct-of-clinical-trials-and-communication-of-clinical-trial-results/</loc>
		<lastmod>2009-04-27T07:58:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/17/nonresponder-phenomenon-a-huge-oportunity/</loc>
		<lastmod>2009-04-17T15:23:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/16/glaxo-and-pfizzer-to-merge-hiv-drug-units-in-new-company-breaking-news/</loc>
		<lastmod>2009-04-16T12:10:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/15/fda-go-mystery-shopping/</loc>
		<lastmod>2009-04-15T08:07:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/03/31/cardiovascular-toxicity-qt-prolongation-in-drug-development-overview/</loc>
		<lastmod>2009-04-14T09:48:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/14/expertise-recognised/</loc>
		<lastmod>2009-04-14T09:25:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/09/priority-review-vouchers-and-there-off/</loc>
		<lastmod>2009-04-09T08:16:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/08/pediatric-exclusivity-after-product-approval-fda-interpriations-about-which-you-might-not-be-aware/</loc>
		<lastmod>2009-04-08T08:21:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/07/gmp-for-phase-1-or-not-gmp-as-the-case-may-be/</loc>
		<lastmod>2009-04-07T13:04:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/03/30/inclusion-of-women-of-child-bearing-potential-new-ich-guidance/</loc>
		<lastmod>2009-03-30T14:28:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/06/10/set-up-a-blog/</loc>
		<lastmod>2009-03-27T09:11:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/06/23/copy-writing-and-proof-reading/</loc>
		<lastmod>2009-03-27T09:10:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/06/25/revised-eu-guidlines-on-medical-devices-vigilance-system/</loc>
		<lastmod>2009-03-27T09:07:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/09/25/book-review-graviational-marketing/</loc>
		<lastmod>2009-03-27T09:07:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/09/29/orphan-drugs-fdaemea-single-application-process/</loc>
		<lastmod>2009-03-27T09:06:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/10/07/paediatric-investigation-plans-new-regulations/</loc>
		<lastmod>2009-03-27T09:06:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/10/09/saving-the-world-at-work-book-review/</loc>
		<lastmod>2009-03-27T09:05:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/10/14/drug-rd-licensing-economy-was-us340bn-in-2007/</loc>
		<lastmod>2009-03-27T09:05:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/10/28/adaptive-clinical-trial-designs/</loc>
		<lastmod>2009-03-27T09:04:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/10/28/leukaemia-60-years-of-progress-its-what-we-work-for/</loc>
		<lastmod>2009-03-27T09:03:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/11/19/course-the-regulations-of-phase-iii-clinical-trials/</loc>
		<lastmod>2009-03-27T09:02:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/11/25/fast-solubilisation-for-proof-of-concept-and-safety-animal-work/</loc>
		<lastmod>2009-03-27T09:02:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/12/08/eden-biodesign-accelerating-novel-vaccine-development/</loc>
		<lastmod>2009-03-27T09:02:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/01/06/conditional-approval-an-important-short-cut-to-the-market/</loc>
		<lastmod>2009-03-27T09:01:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/01/13/new-fda-review-rules-new-emea-fda-paediatric-rules-and-new-emea-safety-rules-are-going-to-torpedo-your-development-project-and-knock-a-large-amount-of-the-value-out-for-your-ip-if-your-not-ready/</loc>
		<lastmod>2009-03-27T09:01:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/01/19/data-exclusivity-extends-market-protection-to-11-years-without-a-patent-being-required/</loc>
		<lastmod>2009-03-27T09:00:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/01/26/neglected-diseases-fda-review-vouchers-a-new-source-of-revenue/</loc>
		<lastmod>2009-03-27T09:00:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/02/20/ectd-electronic-common-technical-document/</loc>
		<lastmod>2009-03-27T08:59:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/03/04/access-to-finance-new-yorkshire-forward-initative/</loc>
		<lastmod>2009-03-27T08:59:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/03/12/clinical-trials-in-eastern-europe/</loc>
		<lastmod>2009-03-27T08:58:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/03/25/bioequivalence-of-therapeutic-proteins/</loc>
		<lastmod>2009-03-25T09:37:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/biotechnology/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/book-review/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/business/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/clinical/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/devices/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/diagnostic/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/discovery/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/drug-delivery/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/ema/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/emea/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/formulation/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/fund-raising/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/herbal/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/job/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/labeling/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/licensing/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/manufacturing/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/market-access/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/marketing/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/medical-report/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/medical-translation/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/pre-clinical/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/regulatory/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/report/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/sidebar/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/sidenotes/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/technical-blog/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/technical-writing/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/testamonial/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/translation/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/uncategorized/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/vaccine/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/veterinary-2/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/category/video/</loc>
		<changefreq>weekly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/02/</loc>
		<lastmod>2012-02-20T16:42:09+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2012/01/</loc>
		<lastmod>2012-01-31T10:57:29+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/12/</loc>
		<lastmod>2011-12-31T09:52:39+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/11/</loc>
		<lastmod>2011-11-30T11:02:46+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/10/</loc>
		<lastmod>2011-10-31T17:51:07+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/09/</loc>
		<lastmod>2011-09-30T11:23:28+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/08/</loc>
		<lastmod>2011-08-31T10:18:09+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/07/</loc>
		<lastmod>2011-07-31T11:54:09+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/06/</loc>
		<lastmod>2011-06-30T09:42:51+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/05/</loc>
		<lastmod>2011-05-31T15:51:23+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/04/</loc>
		<lastmod>2011-04-27T08:58:18+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/03/</loc>
		<lastmod>2011-03-31T15:41:47+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/02/</loc>
		<lastmod>2011-02-28T10:22:42+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2011/01/</loc>
		<lastmod>2011-01-31T10:26:31+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/12/</loc>
		<lastmod>2010-12-31T09:32:37+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/11/</loc>
		<lastmod>2010-11-30T09:45:25+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/10/</loc>
		<lastmod>2010-10-31T13:47:41+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/09/</loc>
		<lastmod>2010-09-30T07:36:14+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/08/</loc>
		<lastmod>2010-08-31T14:57:51+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/07/</loc>
		<lastmod>2010-07-31T09:32:04+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/06/</loc>
		<lastmod>2010-06-30T07:38:36+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/05/</loc>
		<lastmod>2010-05-30T08:35:21+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/04/</loc>
		<lastmod>2010-04-12T08:44:11+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/03/</loc>
		<lastmod>2010-03-31T08:48:00+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/02/</loc>
		<lastmod>2010-02-28T13:20:00+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2010/01/</loc>
		<lastmod>2010-01-31T13:20:00+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/12/</loc>
		<lastmod>2009-12-31T09:54:04+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/11/</loc>
		<lastmod>2009-11-30T09:54:27+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/10/</loc>
		<lastmod>2009-10-31T11:10:54+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/09/</loc>
		<lastmod>2009-09-30T09:27:12+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/08/</loc>
		<lastmod>2009-08-30T14:20:00+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/07/</loc>
		<lastmod>2009-07-31T07:13:29+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/06/</loc>
		<lastmod>2009-06-29T11:38:43+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/05/</loc>
		<lastmod>2009-05-29T09:10:50+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/04/</loc>
		<lastmod>2009-04-29T08:07:57+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/03/</loc>
		<lastmod>2009-03-31T16:48:21+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/02/</loc>
		<lastmod>2009-02-20T13:56:56+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2009/01/</loc>
		<lastmod>2009-01-26T13:47:03+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/12/</loc>
		<lastmod>2008-12-08T13:24:50+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/11/</loc>
		<lastmod>2008-11-25T15:42:02+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/10/</loc>
		<lastmod>2008-10-28T10:22:41+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/09/</loc>
		<lastmod>2008-09-29T08:38:52+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/2008/06/</loc>
		<lastmod>2008-06-25T08:45:15+00:00</lastmod>
		<changefreq>yearly</changefreq>
		<priority>0.3</priority>
	</url>
	<url>
		<loc>http://www.damienbove.com/forum/ask-the-experts/atmp-regulations-in-europe/</loc>
		<lastmod>2012-02-17T08:57:25+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>0.5</priority>
	</url>
</urlset>
